CA2423701A1 - Oxidoreductases - Google Patents

Oxidoreductases Download PDF

Info

Publication number: CA2423701A1
Authority: CA; Canada
Prior art keywords: polynucleotide; polypeptide; seq; sequence; oxired
Prior art date: 2000-09-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002423701A

Other languages

English (en)

French (fr)

Inventor

Mariah R. Baughn

Henry Yue

Catherine M. Tribouley

Ernestine A. Lee

April J.A. Hafalia

Madhu S. Sanjanwala

Monique G. Yao

Li Ding

Vicki S. Elliott

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Incyte Genomics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-29

Filing date

2001-09-28

Publication date

2002-04-04

2001-09-28 Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc

2002-04-04 Publication of CA2423701A1 publication Critical patent/CA2423701A1/en

Status Abandoned legal-status Critical Current

Links

108090000854 Oxidoreductases Proteins 0.000 title claims abstract description 270
102000004316 Oxidoreductases Human genes 0.000 title claims abstract description 269
102000040430 polynucleotide Human genes 0.000 claims abstract description 287
108091033319 polynucleotide Proteins 0.000 claims abstract description 287
239000002157 polynucleotide Substances 0.000 claims abstract description 287
238000000034 method Methods 0.000 claims abstract description 168
230000014509 gene expression Effects 0.000 claims abstract description 99
239000005557 antagonist Substances 0.000 claims abstract description 18
239000000556 agonist Substances 0.000 claims abstract description 17
108090000765 processed proteins & peptides Proteins 0.000 claims description 224
102000004196 processed proteins & peptides Human genes 0.000 claims description 213
229920001184 polypeptide Polymers 0.000 claims description 206
210000004027 cell Anatomy 0.000 claims description 142
239000012634 fragment Substances 0.000 claims description 117
125000003275 alpha amino acid group Chemical group 0.000 claims description 100
150000001875 compounds Chemical class 0.000 claims description 99
239000000523 sample Substances 0.000 claims description 77
230000000694 effects Effects 0.000 claims description 72
150000007523 nucleic acids Chemical class 0.000 claims description 72
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 67
239000002773 nucleotide Substances 0.000 claims description 61
125000003729 nucleotide group Chemical group 0.000 claims description 60
239000000203 mixture Substances 0.000 claims description 56
238000009396 hybridization Methods 0.000 claims description 52
238000012360 testing method Methods 0.000 claims description 44
102000039446 nucleic acids Human genes 0.000 claims description 38
108020004707 nucleic acids Proteins 0.000 claims description 38
230000000295 complement effect Effects 0.000 claims description 35
201000010099 disease Diseases 0.000 claims description 34
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 33
230000027455 binding Effects 0.000 claims description 33
108091034117 Oligonucleotide Proteins 0.000 claims description 29
239000000758 substrate Substances 0.000 claims description 28
238000004519 manufacturing process Methods 0.000 claims description 25
230000015572 biosynthetic process Effects 0.000 claims description 23
238000012216 screening Methods 0.000 claims description 23
238000011282 treatment Methods 0.000 claims description 21
230000002163 immunogen Effects 0.000 claims description 19
241001465754 Metazoa Species 0.000 claims description 18
239000012472 biological sample Substances 0.000 claims description 15
230000003247 decreasing effect Effects 0.000 claims description 11
230000008859 change Effects 0.000 claims description 9
238000002493 microarray Methods 0.000 claims description 9
239000000546 pharmaceutical excipient Substances 0.000 claims description 8
230000009870 specific binding Effects 0.000 claims description 8
231100000419 toxicity Toxicity 0.000 claims description 8
230000001988 toxicity Effects 0.000 claims description 8
230000009261 transgenic effect Effects 0.000 claims description 8
238000012408 PCR amplification Methods 0.000 claims description 5
239000007787 solid Substances 0.000 claims description 5
108060003951 Immunoglobulin Proteins 0.000 claims description 4
102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims description 4
108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims description 4
210000004408 hybridoma Anatomy 0.000 claims description 4
102000018358 immunoglobulin Human genes 0.000 claims description 4
238000012258 culturing Methods 0.000 claims description 3
230000003053 immunization Effects 0.000 claims description 3
238000002372 labelling Methods 0.000 claims description 3
230000002018 overexpression Effects 0.000 claims description 2
230000005875 antibody response Effects 0.000 claims 2
210000000628 antibody-producing cell Anatomy 0.000 claims 2
238000002405 diagnostic procedure Methods 0.000 claims 1
241000282414 Homo sapiens Species 0.000 abstract description 33
239000013604 expression vector Substances 0.000 abstract description 18
230000001594 aberrant effect Effects 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 description 123
102000004169 proteins and genes Human genes 0.000 description 79
235000018102 proteins Nutrition 0.000 description 73
102000004190 Enzymes Human genes 0.000 description 61
108090000790 Enzymes Proteins 0.000 description 61
229940088598 enzyme Drugs 0.000 description 60
239000013598 vector Substances 0.000 description 53
108020004414 DNA Proteins 0.000 description 50
108091028043 Nucleic acid sequence Proteins 0.000 description 41
235000001014 amino acid Nutrition 0.000 description 38
-1 hydroxyl ions Chemical class 0.000 description 34
239000002299 complementary DNA Substances 0.000 description 33
208000035475 disorder Diseases 0.000 description 33
229940024606 amino acid Drugs 0.000 description 31
150000001413 amino acids Chemical class 0.000 description 31
238000002869 basic local alignment search tool Methods 0.000 description 31
206010028980 Neoplasm Diseases 0.000 description 30
210000003470 mitochondria Anatomy 0.000 description 30
210000001519 tissue Anatomy 0.000 description 30
238000004458 analytical method Methods 0.000 description 29
239000013615 primer Substances 0.000 description 29
238000007254 oxidation reaction Methods 0.000 description 25
201000011510 cancer Diseases 0.000 description 23
108010070675 Glutathione transferase Proteins 0.000 description 21
102000005720 Glutathione transferase Human genes 0.000 description 21
238000003556 assay Methods 0.000 description 21
RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 21
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 20
239000003814 drug Substances 0.000 description 20
238000006467 substitution reaction Methods 0.000 description 20
125000000539 amino acid group Chemical group 0.000 description 19
108091028664 Ribonucleotide Proteins 0.000 description 18
230000006870 function Effects 0.000 description 18
239000002336 ribonucleotide Substances 0.000 description 18
239000001177 diphosphate Substances 0.000 description 17
235000011180 diphosphates Nutrition 0.000 description 17
125000002652 ribonucleotide group Chemical group 0.000 description 17
238000006243 chemical reaction Methods 0.000 description 16
230000000875 corresponding effect Effects 0.000 description 16
230000001225 therapeutic effect Effects 0.000 description 16
230000007812 deficiency Effects 0.000 description 15
230000000692 anti-sense effect Effects 0.000 description 14
XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 14
229940079593 drug Drugs 0.000 description 14
230000001965 increasing effect Effects 0.000 description 14
238000004422 calculation algorithm Methods 0.000 description 13
238000005516 engineering process Methods 0.000 description 13
230000001105 regulatory effect Effects 0.000 description 13
230000003612 virological effect Effects 0.000 description 13
XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 12
230000002068 genetic effect Effects 0.000 description 12
238000000338 in vitro Methods 0.000 description 12
210000004072 lung Anatomy 0.000 description 12
229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 12
241000894007 species Species 0.000 description 12
238000003786 synthesis reaction Methods 0.000 description 12
108060008226 thioredoxin Proteins 0.000 description 12
102000017278 Glutaredoxin Human genes 0.000 description 11
108050005205 Glutaredoxin Proteins 0.000 description 11
241000700159 Rattus Species 0.000 description 11
230000001419 dependent effect Effects 0.000 description 11
230000000858 peroxisomal effect Effects 0.000 description 11
238000002360 preparation method Methods 0.000 description 11
238000006722 reduction reaction Methods 0.000 description 11
230000035897 transcription Effects 0.000 description 11
238000013518 transcription Methods 0.000 description 11
238000013519 translation Methods 0.000 description 11
230000014616 translation Effects 0.000 description 11
YVLPJIGOMTXXLP-UHFFFAOYSA-N 15-cis-phytoene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C YVLPJIGOMTXXLP-UHFFFAOYSA-N 0.000 description 10
241000700584 Simplexvirus Species 0.000 description 10
230000001580 bacterial effect Effects 0.000 description 10
235000021466 carotenoid Nutrition 0.000 description 10
238000001415 gene therapy Methods 0.000 description 10
229960003180 glutathione Drugs 0.000 description 10
230000008569 process Effects 0.000 description 10
230000009467 reduction Effects 0.000 description 10
241001430294 unidentified retrovirus Species 0.000 description 10
108010021809 Alcohol dehydrogenase Proteins 0.000 description 9
108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 9
108091035707 Consensus sequence Proteins 0.000 description 9
241000196324 Embryophyta Species 0.000 description 9
108010023922 Enoyl-CoA hydratase Proteins 0.000 description 9
102000011426 Enoyl-CoA hydratase Human genes 0.000 description 9
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
102000003983 Flavoproteins Human genes 0.000 description 9
108010057573 Flavoproteins Proteins 0.000 description 9
241000124008 Mammalia Species 0.000 description 9
150000001747 carotenoids Chemical class 0.000 description 9
230000007547 defect Effects 0.000 description 9
239000003112 inhibitor Substances 0.000 description 9
230000004048 modification Effects 0.000 description 9
238000012986 modification Methods 0.000 description 9
108010001545 phytoene dehydrogenase Proteins 0.000 description 9
239000013612 plasmid Substances 0.000 description 9
239000002243 precursor Substances 0.000 description 9
230000002829 reductive effect Effects 0.000 description 9
239000000126 substance Substances 0.000 description 9
108010001058 Acyl-CoA Dehydrogenase Proteins 0.000 description 8
102000002735 Acyl-CoA Dehydrogenase Human genes 0.000 description 8
102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 8
241000710929 Alphavirus Species 0.000 description 8
241000894006 Bacteria Species 0.000 description 8
108091026890 Coding region Proteins 0.000 description 8
108700024394 Exon Proteins 0.000 description 8
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
108010038807 Oligopeptides Proteins 0.000 description 8
102000015636 Oligopeptides Human genes 0.000 description 8
108091093037 Peptide nucleic acid Proteins 0.000 description 8
240000004808 Saccharomyces cerevisiae Species 0.000 description 8
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 8
238000007792 addition Methods 0.000 description 8
230000003321 amplification Effects 0.000 description 8
230000004071 biological effect Effects 0.000 description 8
239000003795 chemical substances by application Substances 0.000 description 8
238000001514 detection method Methods 0.000 description 8
230000001939 inductive effect Effects 0.000 description 8
210000004185 liver Anatomy 0.000 description 8
239000003550 marker Substances 0.000 description 8
238000003199 nucleic acid amplification method Methods 0.000 description 8
230000037361 pathway Effects 0.000 description 8
238000012163 sequencing technique Methods 0.000 description 8
238000001890 transfection Methods 0.000 description 8
108090000994 Catalytic RNA Proteins 0.000 description 7
102000053642 Catalytic RNA Human genes 0.000 description 7
108020005199 Dehydrogenases Proteins 0.000 description 7
241000588724 Escherichia coli Species 0.000 description 7
102000006587 Glutathione peroxidase Human genes 0.000 description 7
108700016172 Glutathione peroxidases Proteins 0.000 description 7
101000617823 Homo sapiens Solute carrier organic anion transporter family member 6A1 Proteins 0.000 description 7
206010061218 Inflammation Diseases 0.000 description 7
102100036407 Thioredoxin Human genes 0.000 description 7
208000006673 asthma Diseases 0.000 description 7
238000012217 deletion Methods 0.000 description 7
230000037430 deletion Effects 0.000 description 7
238000003745 diagnosis Methods 0.000 description 7
230000002526 effect on cardiovascular system Effects 0.000 description 7
239000003623 enhancer Substances 0.000 description 7
108020001507 fusion proteins Proteins 0.000 description 7
102000037865 fusion proteins Human genes 0.000 description 7
208000027866 inflammatory disease Diseases 0.000 description 7
230000002757 inflammatory effect Effects 0.000 description 7
230000004054 inflammatory process Effects 0.000 description 7
210000004379 membrane Anatomy 0.000 description 7
239000012528 membrane Substances 0.000 description 7
208000030159 metabolic disease Diseases 0.000 description 7
230000003647 oxidation Effects 0.000 description 7
230000002062 proliferating effect Effects 0.000 description 7
230000002685 pulmonary effect Effects 0.000 description 7
238000000746 purification Methods 0.000 description 7
108091092562 ribozyme Proteins 0.000 description 7
239000000243 solution Substances 0.000 description 7
235000000346 sugar Nutrition 0.000 description 7
230000009466 transformation Effects 0.000 description 7
241000701161 unidentified adenovirus Species 0.000 description 7
108010051913 15-hydroxyprostaglandin dehydrogenase Proteins 0.000 description 6
102100030489 15-hydroxyprostaglandin dehydrogenase [NAD(+)] Human genes 0.000 description 6
102000004567 6-phosphogluconate dehydrogenase Human genes 0.000 description 6
108020001657 6-phosphogluconate dehydrogenase Proteins 0.000 description 6
201000001320 Atherosclerosis Diseases 0.000 description 6
208000031229 Cardiomyopathies Diseases 0.000 description 6
108020004635 Complementary DNA Proteins 0.000 description 6
208000013016 Hypoglycemia Diseases 0.000 description 6
108010013792 Isovaleryl-CoA Dehydrogenase Proteins 0.000 description 6
102100025392 Isovaleryl-CoA dehydrogenase, mitochondrial Human genes 0.000 description 6
206010025323 Lymphomas Diseases 0.000 description 6
241000699666 Mus <mouse, genus> Species 0.000 description 6
BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 6
206010035226 Plasma cell myeloma Diseases 0.000 description 6
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
206010048676 Sjogren-Larsson Syndrome Diseases 0.000 description 6
241000700605 Viruses Species 0.000 description 6
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 6
239000000427 antigen Substances 0.000 description 6
108091007433 antigens Proteins 0.000 description 6
102000036639 antigens Human genes 0.000 description 6
230000001363 autoimmune Effects 0.000 description 6
238000003776 cleavage reaction Methods 0.000 description 6
238000011161 development Methods 0.000 description 6
230000018109 developmental process Effects 0.000 description 6
235000014113 dietary fatty acids Nutrition 0.000 description 6
239000000284 extract Substances 0.000 description 6
229930195729 fatty acid Natural products 0.000 description 6
239000000194 fatty acid Substances 0.000 description 6
150000004665 fatty acids Chemical class 0.000 description 6
230000028993 immune response Effects 0.000 description 6
238000003018 immunoassay Methods 0.000 description 6
238000001727 in vivo Methods 0.000 description 6
208000014674 injury Diseases 0.000 description 6
238000003780 insertion Methods 0.000 description 6
230000037431 insertion Effects 0.000 description 6
208000032839 leukemia Diseases 0.000 description 6
239000002502 liposome Substances 0.000 description 6
108020004999 messenger RNA Proteins 0.000 description 6
230000035772 mutation Effects 0.000 description 6
229940094443 oxytocics prostaglandins Drugs 0.000 description 6
210000002824 peroxisome Anatomy 0.000 description 6
239000002987 primer (paints) Substances 0.000 description 6
239000000047 product Substances 0.000 description 6
102000003998 progesterone receptors Human genes 0.000 description 6
150000003180 prostaglandins Chemical class 0.000 description 6
230000007017 scission Effects 0.000 description 6
238000002864 sequence alignment Methods 0.000 description 6
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 6
238000012546 transfer Methods 0.000 description 6
230000032258 transport Effects 0.000 description 6
230000008733 trauma Effects 0.000 description 6
241001529453 unidentified herpesvirus Species 0.000 description 6
150000004670 unsaturated fatty acids Chemical class 0.000 description 6
235000021122 unsaturated fatty acids Nutrition 0.000 description 6
YVLPJIGOMTXXLP-UUKUAVTLSA-N 15,15'-cis-Phytoene Natural products C(=C\C=C/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C YVLPJIGOMTXXLP-UUKUAVTLSA-N 0.000 description 5
YVLPJIGOMTXXLP-BAHRDPFUSA-N 15Z-phytoene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/CCC=C(/C)CCC=C(/C)CCC=C(C)C)C)C)C)C YVLPJIGOMTXXLP-BAHRDPFUSA-N 0.000 description 5
208000009270 3-hydroxyacyl-CoA dehydrogenase deficiency Diseases 0.000 description 5
102000007698 Alcohol dehydrogenase Human genes 0.000 description 5
208000031212 Autoimmune polyendocrinopathy Diseases 0.000 description 5
101710088194 Dehydrogenase Proteins 0.000 description 5
BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 5
201000010374 Down Syndrome Diseases 0.000 description 5
241000282412 Homo Species 0.000 description 5
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
108010044467 Isoenzymes Proteins 0.000 description 5
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 5
101001110310 Lentilactobacillus kefiri NADP-dependent (R)-specific alcohol dehydrogenase Proteins 0.000 description 5
102000018653 Long-Chain Acyl-CoA Dehydrogenase Human genes 0.000 description 5
108010027062 Long-Chain Acyl-CoA Dehydrogenase Proteins 0.000 description 5
241000283973 Oryctolagus cuniculus Species 0.000 description 5
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
238000009825 accumulation Methods 0.000 description 5
238000010171 animal model Methods 0.000 description 5
230000001588 bifunctional effect Effects 0.000 description 5
210000001124 body fluid Anatomy 0.000 description 5
210000004556 brain Anatomy 0.000 description 5
230000015556 catabolic process Effects 0.000 description 5
230000003197 catalytic effect Effects 0.000 description 5
230000001413 cellular effect Effects 0.000 description 5
239000003153 chemical reaction reagent Substances 0.000 description 5
238000010367 cloning Methods 0.000 description 5
238000010276 construction Methods 0.000 description 5
230000007423 decrease Effects 0.000 description 5
230000002950 deficient Effects 0.000 description 5
239000005547 deoxyribonucleotide Substances 0.000 description 5
238000001784 detoxification Methods 0.000 description 5
230000036267 drug metabolism Effects 0.000 description 5
230000002255 enzymatic effect Effects 0.000 description 5
238000009472 formulation Methods 0.000 description 5
230000013595 glycosylation Effects 0.000 description 5
238000006206 glycosylation reaction Methods 0.000 description 5
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical class O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 5
LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 5
230000002218 hypoglycaemic effect Effects 0.000 description 5
208000015181 infectious disease Diseases 0.000 description 5
230000005764 inhibitory process Effects 0.000 description 5
230000003993 interaction Effects 0.000 description 5
230000003834 intracellular effect Effects 0.000 description 5
210000003734 kidney Anatomy 0.000 description 5
229920002521 macromolecule Polymers 0.000 description 5
230000007246 mechanism Effects 0.000 description 5
230000001404 mediated effect Effects 0.000 description 5
201000001441 melanoma Diseases 0.000 description 5
230000000926 neurological effect Effects 0.000 description 5
BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 5
210000001672 ovary Anatomy 0.000 description 5
238000004806 packaging method and process Methods 0.000 description 5
210000000496 pancreas Anatomy 0.000 description 5
235000011765 phytoene Nutrition 0.000 description 5
102000054765 polymorphisms of proteins Human genes 0.000 description 5
230000002265 prevention Effects 0.000 description 5
102000005962 receptors Human genes 0.000 description 5
108020003175 receptors Proteins 0.000 description 5
230000010076 replication Effects 0.000 description 5
150000003384 small molecules Chemical class 0.000 description 5
208000011580 syndromic disease Diseases 0.000 description 5
210000001550 testis Anatomy 0.000 description 5
229940094937 thioredoxin Drugs 0.000 description 5
231100000331 toxic Toxicity 0.000 description 5
230000002588 toxic effect Effects 0.000 description 5
238000002054 transplantation Methods 0.000 description 5
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
102000009724 2,4-dienoyl-CoA reductase Human genes 0.000 description 4
108010020180 2,4-dienoyl-CoA reductase Proteins 0.000 description 4
BIRSGZKFKXLSJQ-SQOUGZDYSA-N 6-Phospho-D-gluconate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O BIRSGZKFKXLSJQ-SQOUGZDYSA-N 0.000 description 4
IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 4
208000019932 Aciduria Diseases 0.000 description 4
206010002383 Angina Pectoris Diseases 0.000 description 4
102100036465 Autoimmune regulator Human genes 0.000 description 4
108020004705 Codon Proteins 0.000 description 4
208000008448 Congenital adrenal hyperplasia Diseases 0.000 description 4
102000053602 DNA Human genes 0.000 description 4
238000001712 DNA sequencing Methods 0.000 description 4
201000010385 Dihydropyrimidine Dehydrogenase Deficiency Diseases 0.000 description 4
206010014561 Emphysema Diseases 0.000 description 4
241000206602 Eukaryota Species 0.000 description 4
201000011240 Frontotemporal dementia Diseases 0.000 description 4
108700006770 Glutaric Acidemia I Proteins 0.000 description 4
108010024636 Glutathione Proteins 0.000 description 4
208000024869 Goodpasture syndrome Diseases 0.000 description 4
208000030836 Hashimoto thyroiditis Diseases 0.000 description 4
101710154606 Hemagglutinin Proteins 0.000 description 4
101000928549 Homo sapiens Autoimmune regulator Proteins 0.000 description 4
208000023105 Huntington disease Diseases 0.000 description 4
102100030358 Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial Human genes 0.000 description 4
101710150008 Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial Proteins 0.000 description 4
208000015074 Hyperinsulinism-hyperammonemia syndrome Diseases 0.000 description 4
206010020772 Hypertension Diseases 0.000 description 4
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
229930184725 Lipoxin Natural products 0.000 description 4
208000019693 Lung disease Diseases 0.000 description 4
208000003250 Mixed connective tissue disease Diseases 0.000 description 4
241000699670 Mus sp. Species 0.000 description 4
208000021642 Muscular disease Diseases 0.000 description 4
101710093908 Outer capsid protein VP4 Proteins 0.000 description 4
101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 4
101710176177 Protein A56 Proteins 0.000 description 4
102000006010 Protein Disulfide-Isomerase Human genes 0.000 description 4
108010076504 Protein Sorting Signals Proteins 0.000 description 4
201000004681 Psoriasis Diseases 0.000 description 4
206010037394 Pulmonary haemorrhage Diseases 0.000 description 4
201000007981 Reye syndrome Diseases 0.000 description 4
102000028649 Ribonucleoside-diphosphate reductase Human genes 0.000 description 4
108010038105 Ribonucleoside-diphosphate reductase Proteins 0.000 description 4
241000714474 Rous sarcoma virus Species 0.000 description 4
206010039491 Sarcoma Diseases 0.000 description 4
238000012300 Sequence Analysis Methods 0.000 description 4
108091081024 Start codon Proteins 0.000 description 4
102000002933 Thioredoxin Human genes 0.000 description 4
102100036502 Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase Human genes 0.000 description 4
206010068233 Trimethylaminuria Diseases 0.000 description 4
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical group O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
201000011032 Werner Syndrome Diseases 0.000 description 4
208000009956 adenocarcinoma Diseases 0.000 description 4
210000004100 adrenal gland Anatomy 0.000 description 4
208000003455 anaphylaxis Diseases 0.000 description 4
208000007502 anemia Diseases 0.000 description 4
238000000137 annealing Methods 0.000 description 4
DQEPMTIXHXSFOR-ZGXWSNOMSA-N anti-diolepoxide Chemical class C1=C2C([C@@H]3O[C@@H]3[C@@H]([C@H]3O)O)=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 DQEPMTIXHXSFOR-ZGXWSNOMSA-N 0.000 description 4
230000000890 antigenic effect Effects 0.000 description 4
208000011775 arteriosclerosis disease Diseases 0.000 description 4
201000009771 autoimmune polyendocrine syndrome type 1 Diseases 0.000 description 4
230000033228 biological regulation Effects 0.000 description 4
210000000988 bone and bone Anatomy 0.000 description 4
210000001185 bone marrow Anatomy 0.000 description 4
210000000481 breast Anatomy 0.000 description 4
206010006451 bronchitis Diseases 0.000 description 4
150000001720 carbohydrates Chemical class 0.000 description 4
235000014633 carbohydrates Nutrition 0.000 description 4
238000004113 cell culture Methods 0.000 description 4
210000003679 cervix uteri Anatomy 0.000 description 4
201000001981 dermatomyositis Diseases 0.000 description 4
206010014665 endocarditis Diseases 0.000 description 4
206010015037 epilepsy Diseases 0.000 description 4
201000002123 familial hyperinsulinemic hypoglycemia 6 Diseases 0.000 description 4
210000000232 gallbladder Anatomy 0.000 description 4
210000000609 ganglia Anatomy 0.000 description 4
210000001035 gastrointestinal tract Anatomy 0.000 description 4
210000002216 heart Anatomy 0.000 description 4
239000000185 hemagglutinin Substances 0.000 description 4
239000003446 ligand Substances 0.000 description 4
150000002639 lipoxins Chemical class 0.000 description 4
210000004962 mammalian cell Anatomy 0.000 description 4
239000000463 material Substances 0.000 description 4
201000006417 multiple sclerosis Diseases 0.000 description 4
210000003205 muscle Anatomy 0.000 description 4
201000006938 muscular dystrophy Diseases 0.000 description 4
206010028417 myasthenia gravis Diseases 0.000 description 4
201000000050 myeloid neoplasm Diseases 0.000 description 4
208000010125 myocardial infarction Diseases 0.000 description 4
229910052760 oxygen Inorganic materials 0.000 description 4
239000001301 oxygen Substances 0.000 description 4
230000000849 parathyroid Effects 0.000 description 4
210000003899 penis Anatomy 0.000 description 4
229920000642 polymer Polymers 0.000 description 4
208000005987 polymyositis Diseases 0.000 description 4
238000012545 processing Methods 0.000 description 4
210000002307 prostate Anatomy 0.000 description 4
108020003519 protein disulfide isomerase Proteins 0.000 description 4
230000005855 radiation Effects 0.000 description 4
238000003127 radioimmunoassay Methods 0.000 description 4
238000011160 research Methods 0.000 description 4
230000004044 response Effects 0.000 description 4
206010039073 rheumatoid arthritis Diseases 0.000 description 4
210000003079 salivary gland Anatomy 0.000 description 4
208000012672 seasonal affective disease Diseases 0.000 description 4
230000035939 shock Effects 0.000 description 4
210000003491 skin Anatomy 0.000 description 4
210000000952 spleen Anatomy 0.000 description 4
150000008163 sugars Chemical class 0.000 description 4
201000000596 systemic lupus erythematosus Diseases 0.000 description 4
208000001608 teratocarcinoma Diseases 0.000 description 4
238000002560 therapeutic procedure Methods 0.000 description 4
150000003573 thiols Chemical class 0.000 description 4
201000005060 thrombophlebitis Diseases 0.000 description 4
210000001541 thymus gland Anatomy 0.000 description 4
210000001685 thyroid gland Anatomy 0.000 description 4
210000003932 urinary bladder Anatomy 0.000 description 4
210000004291 uterus Anatomy 0.000 description 4
150000004669 very long chain fatty acids Chemical class 0.000 description 4
239000002676 xenobiotic agent Substances 0.000 description 4
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 3
108010074197 15-Oxoprostaglandin 13-Reductase Proteins 0.000 description 3
102000028742 15-oxoprostaglandin 13-reductase Human genes 0.000 description 3
208000030507 AIDS Diseases 0.000 description 3
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
102000004539 Acyl-CoA Oxidase Human genes 0.000 description 3
108020001558 Acyl-CoA oxidase Proteins 0.000 description 3
206010001605 Alcohol poisoning Diseases 0.000 description 3
241000972773 Aulopiformes Species 0.000 description 3
241000283690 Bos taurus Species 0.000 description 3
208000005623 Carcinogenesis Diseases 0.000 description 3
208000024172 Cardiovascular disease Diseases 0.000 description 3
206010058892 Carnitine deficiency Diseases 0.000 description 3
206010053684 Cerebrohepatorenal syndrome Diseases 0.000 description 3
ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 3
206010010904 Convulsion Diseases 0.000 description 3
201000003883 Cystic fibrosis Diseases 0.000 description 3
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
230000006820 DNA synthesis Effects 0.000 description 3
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 3
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 3
238000002965 ELISA Methods 0.000 description 3
108010088842 Fibrinolysin Proteins 0.000 description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
108010025076 Holoenzymes Proteins 0.000 description 3
241000725303 Human immunodeficiency virus Species 0.000 description 3
108700040030 Hyperprolinemia type 2 Proteins 0.000 description 3
206010020751 Hypersensitivity Diseases 0.000 description 3
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 3
GRSZFWQUAKGDAV-KQYNXXCUSA-N IMP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-KQYNXXCUSA-N 0.000 description 3
108010087227 IMP Dehydrogenase Proteins 0.000 description 3
102000006674 IMP dehydrogenase Human genes 0.000 description 3
108091092195 Intron Proteins 0.000 description 3
208000000420 Isovaleric acidemia Diseases 0.000 description 3
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
108010051910 Long-chain-3-hydroxyacyl-CoA dehydrogenase Proteins 0.000 description 3
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
239000004472 Lysine Substances 0.000 description 3
101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 3
108700000232 Medium chain acyl CoA dehydrogenase deficiency Proteins 0.000 description 3
208000036626 Mental retardation Diseases 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
208000018909 Neonatal adrenoleukodystrophy Diseases 0.000 description 3
208000020547 Peroxisomal disease Diseases 0.000 description 3
208000008425 Protein deficiency Diseases 0.000 description 3
WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 3
108020004511 Recombinant DNA Proteins 0.000 description 3
241000710961 Semliki Forest virus Species 0.000 description 3
108700017825 Short chain Acyl CoA dehydrogenase deficiency Proteins 0.000 description 3
OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical class [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 3
102000006601 Thymidine Kinase Human genes 0.000 description 3
108020004440 Thymidine kinase Proteins 0.000 description 3
241000723873 Tobacco mosaic virus Species 0.000 description 3
108010039246 Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase Proteins 0.000 description 3
102000040945 Transcription factor Human genes 0.000 description 3
108091023040 Transcription factor Proteins 0.000 description 3
102000004357 Transferases Human genes 0.000 description 3
108090000992 Transferases Proteins 0.000 description 3
108700036262 Trifunctional Protein Deficiency With Myopathy And Neuropathy Proteins 0.000 description 3
206010044688 Trisomy 21 Diseases 0.000 description 3
241000700618 Vaccinia virus Species 0.000 description 3
208000036142 Viral infection Diseases 0.000 description 3
102100023038 WD and tetratricopeptide repeats protein 1 Human genes 0.000 description 3
201000004525 Zellweger Syndrome Diseases 0.000 description 3
208000036813 Zellweger spectrum disease Diseases 0.000 description 3
239000004480 active ingredient Substances 0.000 description 3
230000001154 acute effect Effects 0.000 description 3
239000002671 adjuvant Substances 0.000 description 3
230000007815 allergy Effects 0.000 description 3
238000013459 approach Methods 0.000 description 3
125000005605 benzo group Chemical group 0.000 description 3
206010067728 beta-ketothiolase deficiency Diseases 0.000 description 3
210000002459 blastocyst Anatomy 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000008280 blood Substances 0.000 description 3
239000010839 body fluid Substances 0.000 description 3
230000036952 cancer formation Effects 0.000 description 3
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
231100000504 carcinogenesis Toxicity 0.000 description 3
230000000747 cardiac effect Effects 0.000 description 3
229960004203 carnitine Drugs 0.000 description 3
230000004663 cell proliferation Effects 0.000 description 3
210000003169 central nervous system Anatomy 0.000 description 3
230000001684 chronic effect Effects 0.000 description 3
235000017471 coenzyme Q10 Nutrition 0.000 description 3
239000003184 complementary RNA Substances 0.000 description 3
230000009918 complex formation Effects 0.000 description 3
230000021615 conjugation Effects 0.000 description 3
125000000151 cysteine group Chemical class N[C@@H](CS)C(=O)* 0.000 description 3
230000001086 cytosolic effect Effects 0.000 description 3
229940127089 cytotoxic agent Drugs 0.000 description 3
239000002254 cytotoxic agent Substances 0.000 description 3
230000006378 damage Effects 0.000 description 3
125000002637 deoxyribonucleotide group Chemical group 0.000 description 3
206010012601 diabetes mellitus Diseases 0.000 description 3
210000002472 endoplasmic reticulum Anatomy 0.000 description 3
210000003527 eukaryotic cell Anatomy 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
230000002538 fungal effect Effects 0.000 description 3
239000000499 gel Substances 0.000 description 3
238000010353 genetic engineering Methods 0.000 description 3
239000008103 glucose Substances 0.000 description 3
208000007475 hemolytic anemia Diseases 0.000 description 3
238000002744 homologous recombination Methods 0.000 description 3
230000006801 homologous recombination Effects 0.000 description 3
210000000688 human artificial chromosome Anatomy 0.000 description 3
102000001718 human gonad-specific transporter Human genes 0.000 description 3
238000002347 injection Methods 0.000 description 3
239000007924 injection Substances 0.000 description 3
235000013902 inosinic acid Nutrition 0.000 description 3
239000000543 intermediate Substances 0.000 description 3
229910052742 iron Inorganic materials 0.000 description 3
108700036927 isovaleric Acidemia Proteins 0.000 description 3
150000002632 lipids Chemical class 0.000 description 3
150000004668 long chain fatty acids Chemical class 0.000 description 3
239000011159 matrix material Substances 0.000 description 3
208000005548 medium chain acyl-CoA dehydrogenase deficiency Diseases 0.000 description 3
150000004667 medium chain fatty acids Chemical class 0.000 description 3
230000004060 metabolic process Effects 0.000 description 3
239000002207 metabolite Substances 0.000 description 3
244000005700 microbiome Species 0.000 description 3
230000002438 mitochondrial effect Effects 0.000 description 3
238000010369 molecular cloning Methods 0.000 description 3
231100000350 mutagenesis Toxicity 0.000 description 3
231100000219 mutagenic Toxicity 0.000 description 3
230000003505 mutagenic effect Effects 0.000 description 3
231100000299 mutagenicity Toxicity 0.000 description 3
230000007886 mutagenicity Effects 0.000 description 3
230000001613 neoplastic effect Effects 0.000 description 3
239000008177 pharmaceutical agent Substances 0.000 description 3
230000026731 phosphorylation Effects 0.000 description 3
238000006366 phosphorylation reaction Methods 0.000 description 3
229940012957 plasmin Drugs 0.000 description 3
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
230000000644 propagated effect Effects 0.000 description 3
230000006337 proteolytic cleavage Effects 0.000 description 3
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
150000003254 radicals Chemical class 0.000 description 3
230000006798 recombination Effects 0.000 description 3
NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 3
235000019515 salmon Nutrition 0.000 description 3
229920006395 saturated elastomer Polymers 0.000 description 3
150000004671 saturated fatty acids Chemical class 0.000 description 3
235000003441 saturated fatty acids Nutrition 0.000 description 3
208000001392 short chain acyl-CoA dehydrogenase deficiency Diseases 0.000 description 3
210000002460 smooth muscle Anatomy 0.000 description 3
239000000600 sorbitol Substances 0.000 description 3
208000016505 systemic primary carnitine deficiency disease Diseases 0.000 description 3
229940113082 thymine Drugs 0.000 description 3
230000002103 transcriptional effect Effects 0.000 description 3
238000010361 transduction Methods 0.000 description 3
230000026683 transduction Effects 0.000 description 3
229940035936 ubiquinone Drugs 0.000 description 3
201000010866 very long chain acyl-CoA dehydrogenase deficiency Diseases 0.000 description 3
238000005406 washing Methods 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 2
ATCICVFRSJQYDV-UHFFFAOYSA-N (6E,8E,10E,12E,14E,16E,18E,20E,22E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,26,30-dodecaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC=C(C)CCC=C(C)C ATCICVFRSJQYDV-UHFFFAOYSA-N 0.000 description 2
MSTNYGQPCMXVAQ-RYUDHWBXSA-N (6S)-5,6,7,8-tetrahydrofolic acid Chemical compound C([C@H]1CNC=2N=C(NC(=O)C=2N1)N)NC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-RYUDHWBXSA-N 0.000 description 2
DXBHBZVCASKNBY-UHFFFAOYSA-N 1,2-Benz(a)anthracene Chemical compound C1=CC=C2C3=CC4=CC=CC=C4C=C3C=CC2=C1 DXBHBZVCASKNBY-UHFFFAOYSA-N 0.000 description 2
AUFGTPPARQZWDO-YPMHNXCESA-N 10-formyltetrahydrofolic acid Chemical compound C([C@H]1CNC=2N=C(NC(=O)C=2N1)N)N(C=O)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 AUFGTPPARQZWDO-YPMHNXCESA-N 0.000 description 2
ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 2
AWKYSZSJPJUFQS-UHFFFAOYSA-N 3,7-dihydropurine-2,6-dione;phosphoric acid Chemical compound OP(O)(O)=O.O=C1NC(=O)NC2=C1NC=N2 AWKYSZSJPJUFQS-UHFFFAOYSA-N 0.000 description 2
102100021834 3-hydroxyacyl-CoA dehydrogenase Human genes 0.000 description 2
101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 2
102100024643 ATP-binding cassette sub-family D member 1 Human genes 0.000 description 2
206010001052 Acute respiratory distress syndrome Diseases 0.000 description 2
208000026872 Addison Disease Diseases 0.000 description 2
229930024421 Adenine Natural products 0.000 description 2
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
102000055025 Adenosine deaminases Human genes 0.000 description 2
201000011452 Adrenoleukodystrophy Diseases 0.000 description 2
206010001557 Albinism Diseases 0.000 description 2
108010025188 Alcohol oxidase Proteins 0.000 description 2
102100026608 Aldehyde dehydrogenase family 3 member A2 Human genes 0.000 description 2
208000007887 Alphavirus Infections Diseases 0.000 description 2
208000024985 Alport syndrome Diseases 0.000 description 2
102100034452 Alternative prion protein Human genes 0.000 description 2
206010001881 Alveolar proteinosis Diseases 0.000 description 2
208000024827 Alzheimer disease Diseases 0.000 description 2
201000000736 Amenorrhea Diseases 0.000 description 2
206010001928 Amenorrhoea Diseases 0.000 description 2
238000010953 Ames test Methods 0.000 description 2
231100000039 Ames test Toxicity 0.000 description 2
208000000044 Amnesia Diseases 0.000 description 2
208000031091 Amnestic disease Diseases 0.000 description 2
206010002198 Anaphylactic reaction Diseases 0.000 description 2
206010002199 Anaphylactic shock Diseases 0.000 description 2
206010002329 Aneurysm Diseases 0.000 description 2
102400000068 Angiostatin Human genes 0.000 description 2
108010079709 Angiostatins Proteins 0.000 description 2
206010002556 Ankylosing Spondylitis Diseases 0.000 description 2
208000019901 Anxiety disease Diseases 0.000 description 2
208000003017 Aortic Valve Stenosis Diseases 0.000 description 2
102000001381 Arachidonate 5-Lipoxygenase Human genes 0.000 description 2
108010093579 Arachidonate 5-lipoxygenase Proteins 0.000 description 2
206010003210 Arteriosclerosis Diseases 0.000 description 2
206010003226 Arteriovenous fistula Diseases 0.000 description 2
BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
206010003598 Atelectasis Diseases 0.000 description 2
208000004300 Atrophic Gastritis Diseases 0.000 description 2
208000023275 Autoimmune disease Diseases 0.000 description 2
208000012219 Autonomic Nervous System disease Diseases 0.000 description 2
201000001178 Bacterial Pneumonia Diseases 0.000 description 2
208000023328 Basedow disease Diseases 0.000 description 2
FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 description 2
206010004552 Bicuspid aortic valve Diseases 0.000 description 2
208000004020 Brain Abscess Diseases 0.000 description 2
208000014644 Brain disease Diseases 0.000 description 2
206010006458 Bronchitis chronic Diseases 0.000 description 2
206010006811 Bursitis Diseases 0.000 description 2
208000004434 Calcinosis Diseases 0.000 description 2
102000000584 Calmodulin Human genes 0.000 description 2
108010041952 Calmodulin Proteins 0.000 description 2
241000282472 Canis lupus familiaris Species 0.000 description 2
108090000565 Capsid Proteins Proteins 0.000 description 2
206010007559 Cardiac failure congestive Diseases 0.000 description 2
241000282693 Cercopithecidae Species 0.000 description 2
102100023321 Ceruloplasmin Human genes 0.000 description 2
108010058733 Choline dehydrogenase Proteins 0.000 description 2
102100032363 Choline dehydrogenase, mitochondrial Human genes 0.000 description 2
241000511343 Chondrostoma nasus Species 0.000 description 2
208000033810 Choroidal dystrophy Diseases 0.000 description 2
208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 2
RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 2
108700010070 Codon Usage Proteins 0.000 description 2
206010009900 Colitis ulcerative Diseases 0.000 description 2
206010009944 Colon cancer Diseases 0.000 description 2
206010010099 Combined immunodeficiency Diseases 0.000 description 2
108020004394 Complementary RNA Proteins 0.000 description 2
208000002330 Congenital Heart Defects Diseases 0.000 description 2
206010010356 Congenital anomaly Diseases 0.000 description 2
208000011990 Corticobasal Degeneration Diseases 0.000 description 2
208000019736 Cranial nerve disease Diseases 0.000 description 2
241000699800 Cricetinae Species 0.000 description 2
208000011231 Crohn disease Diseases 0.000 description 2
208000014311 Cushing syndrome Diseases 0.000 description 2
CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 2
102000003849 Cytochrome P450 Human genes 0.000 description 2
102100025621 Cytochrome b-245 heavy chain Human genes 0.000 description 2
108090000695 Cytokines Proteins 0.000 description 2
102000004127 Cytokines Human genes 0.000 description 2
241000701022 Cytomegalovirus Species 0.000 description 2
HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 2
FNZLKVNUWIIPSJ-UHNVWZDZSA-N D-ribulose 5-phosphate Chemical compound OCC(=O)[C@H](O)[C@H](O)COP(O)(O)=O FNZLKVNUWIIPSJ-UHNVWZDZSA-N 0.000 description 2
108010017826 DNA Polymerase I Proteins 0.000 description 2
102000004594 DNA Polymerase I Human genes 0.000 description 2
239000003155 DNA primer Substances 0.000 description 2
206010012289 Dementia Diseases 0.000 description 2
208000016192 Demyelinating disease Diseases 0.000 description 2
206010012438 Dermatitis atopic Diseases 0.000 description 2
206010012442 Dermatitis contact Diseases 0.000 description 2
208000012239 Developmental disease Diseases 0.000 description 2
208000032131 Diabetic Neuropathies Diseases 0.000 description 2
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 2
206010059866 Drug resistance Diseases 0.000 description 2
206010013801 Duchenne Muscular Dystrophy Diseases 0.000 description 2
208000011345 Duchenne and Becker muscular dystrophy Diseases 0.000 description 2
208000032274 Encephalopathy Diseases 0.000 description 2
206010062608 Endocarditis noninfective Diseases 0.000 description 2
241001635598 Enicostema Species 0.000 description 2
102100021822 Enoyl-CoA hydratase, mitochondrial Human genes 0.000 description 2
206010014950 Eosinophilia Diseases 0.000 description 2
206010015226 Erythema nodosum Diseases 0.000 description 2
206010015251 Erythroblastosis foetalis Diseases 0.000 description 2
208000032027 Essential Thrombocythemia Diseases 0.000 description 2
206010061846 Extradural abscess Diseases 0.000 description 2
206010016654 Fibrosis Diseases 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
108010091861 Formyltetrahydrofolate dehydrogenase Proteins 0.000 description 2
102000040664 GMC oxidoreductase family Human genes 0.000 description 2
108091071066 GMC oxidoreductase family Proteins 0.000 description 2
108010013942 GMP Reductase Proteins 0.000 description 2
102000017179 GMP reductase Human genes 0.000 description 2
208000036495 Gastritis atrophic Diseases 0.000 description 2
208000015872 Gaucher disease Diseases 0.000 description 2
208000003736 Gerstmann-Straussler-Scheinker Disease Diseases 0.000 description 2
206010072075 Gerstmann-Straussler-Scheinker syndrome Diseases 0.000 description 2
206010018364 Glomerulonephritis Diseases 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
201000005569 Gout Diseases 0.000 description 2
208000015023 Graves' disease Diseases 0.000 description 2
206010019280 Heart failures Diseases 0.000 description 2
206010061201 Helminthic infection Diseases 0.000 description 2
208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 description 2
208000009292 Hemophilia A Diseases 0.000 description 2
206010020112 Hirsutism Diseases 0.000 description 2
208000017604 Hodgkin disease Diseases 0.000 description 2
208000010747 Hodgkins lymphoma Diseases 0.000 description 2
206010020575 Hyperammonaemia Diseases 0.000 description 2
206010021143 Hypoxia Diseases 0.000 description 2
201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 description 2
208000009995 Idiopathic pulmonary hemosiderosis Diseases 0.000 description 2
208000026350 Inborn Genetic disease Diseases 0.000 description 2
206010022489 Insulin Resistance Diseases 0.000 description 2
208000029523 Interstitial Lung disease Diseases 0.000 description 2
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
108091026898 Leader sequence (mRNA) Proteins 0.000 description 2
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
208000024369 Libman-Sacks endocarditis Diseases 0.000 description 2
102100029107 Long chain 3-hydroxyacyl-CoA dehydrogenase Human genes 0.000 description 2
108010051074 Long-chain-enoyl-CoA hydratase Proteins 0.000 description 2
206010025327 Lymphopenia Diseases 0.000 description 2
208000001826 Marfan syndrome Diseases 0.000 description 2
108010049137 Member 1 Subfamily D ATP Binding Cassette Transporter Proteins 0.000 description 2
206010027202 Meningitis bacterial Diseases 0.000 description 2
206010027260 Meningitis viral Diseases 0.000 description 2
206010068836 Metabolic myopathy Diseases 0.000 description 2
208000019695 Migraine disease Diseases 0.000 description 2
208000003430 Mitral Valve Prolapse Diseases 0.000 description 2
208000019022 Mood disease Diseases 0.000 description 2
108010047290 Multifunctional Enzymes Proteins 0.000 description 2
102000006833 Multifunctional Enzymes Human genes 0.000 description 2
208000034578 Multiple myelomas Diseases 0.000 description 2
208000029578 Muscle disease Diseases 0.000 description 2
101710135898 Myc proto-oncogene protein Proteins 0.000 description 2
102100038895 Myc proto-oncogene protein Human genes 0.000 description 2
201000008235 Mycoplasma pneumoniae pneumonia Diseases 0.000 description 2
208000003926 Myelitis Diseases 0.000 description 2
208000009525 Myocarditis Diseases 0.000 description 2
201000009623 Myopathy Diseases 0.000 description 2
206010028643 Myopathy endocrine Diseases 0.000 description 2
206010068871 Myotonic dystrophy Diseases 0.000 description 2
208000023137 Myotoxicity Diseases 0.000 description 2
208000012902 Nervous system disease Diseases 0.000 description 2
208000009905 Neurofibromatoses Diseases 0.000 description 2
208000008589 Obesity Diseases 0.000 description 2
108700026244 Open Reading Frames Proteins 0.000 description 2
208000001132 Osteoporosis Diseases 0.000 description 2
206010033645 Pancreatitis Diseases 0.000 description 2
208000027099 Paranoid disease Diseases 0.000 description 2
208000030852 Parasitic disease Diseases 0.000 description 2
208000018737 Parkinson disease Diseases 0.000 description 2
208000000733 Paroxysmal Hemoglobinuria Diseases 0.000 description 2
108700001556 Peroxisomal ACYL-COA oxidase deficiency Proteins 0.000 description 2
102100036050 Phosphatidylinositol N-acetylglucosaminyltransferase subunit A Human genes 0.000 description 2
108010033024 Phospholipid Hydroperoxide Glutathione Peroxidase Proteins 0.000 description 2
102100023410 Phospholipid hydroperoxide glutathione peroxidase Human genes 0.000 description 2
208000000609 Pick Disease of the Brain Diseases 0.000 description 2
206010035610 Pleural Neoplasms Diseases 0.000 description 2
208000002151 Pleural effusion Diseases 0.000 description 2
206010035724 Pneumonia mycoplasmal Diseases 0.000 description 2
206010035737 Pneumonia viral Diseases 0.000 description 2
206010036376 Postherpetic Neuralgia Diseases 0.000 description 2
108091000054 Prion Proteins 0.000 description 2
208000024777 Prion disease Diseases 0.000 description 2
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
108010029485 Protein Isoforms Proteins 0.000 description 2
102000001708 Protein Isoforms Human genes 0.000 description 2
208000007123 Pulmonary Atelectasis Diseases 0.000 description 2
208000010378 Pulmonary Embolism Diseases 0.000 description 2
206010037368 Pulmonary congestion Diseases 0.000 description 2
208000006193 Pulmonary infarction Diseases 0.000 description 2
206010037423 Pulmonary oedema Diseases 0.000 description 2
108020004518 RNA Probes Proteins 0.000 description 2
239000003391 RNA probe Substances 0.000 description 2
206010037779 Radiculopathy Diseases 0.000 description 2
208000003782 Raynaud disease Diseases 0.000 description 2
208000012322 Raynaud phenomenon Diseases 0.000 description 2
FNZLKVNUWIIPSJ-UHFFFAOYSA-N Rbl5P Natural products OCC(=O)C(O)C(O)COP(O)(O)=O FNZLKVNUWIIPSJ-UHFFFAOYSA-N 0.000 description 2
208000005587 Refsum Disease Diseases 0.000 description 2
208000033464 Reiter syndrome Diseases 0.000 description 2
208000013616 Respiratory Distress Syndrome Diseases 0.000 description 2
208000030934 Restrictive pulmonary disease Diseases 0.000 description 2
208000007014 Retinitis pigmentosa Diseases 0.000 description 2
201000000582 Retinoblastoma Diseases 0.000 description 2
PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
206010039710 Scleroderma Diseases 0.000 description 2
108030005950 Short-chain-enoyl-CoA hydratases Proteins 0.000 description 2
241000710960 Sindbis virus Species 0.000 description 2
208000021386 Sjogren Syndrome Diseases 0.000 description 2
208000029033 Spinal Cord disease Diseases 0.000 description 2
208000010112 Spinocerebellar Degenerations Diseases 0.000 description 2
208000006011 Stroke Diseases 0.000 description 2
206010042265 Sturge-Weber Syndrome Diseases 0.000 description 2
201000000002 Subdural Empyema Diseases 0.000 description 2
108091027544 Subgenomic mRNA Proteins 0.000 description 2
241000282887 Suidae Species 0.000 description 2
102000019197 Superoxide Dismutase Human genes 0.000 description 2
108010012715 Superoxide dismutase Proteins 0.000 description 2
201000009594 Systemic Scleroderma Diseases 0.000 description 2
206010042953 Systemic sclerosis Diseases 0.000 description 2
206010043118 Tardive Dyskinesia Diseases 0.000 description 2
208000002903 Thalassemia Diseases 0.000 description 2
102000013090 Thioredoxin-Disulfide Reductase Human genes 0.000 description 2
108010079911 Thioredoxin-disulfide reductase Proteins 0.000 description 2
108091036066 Three prime untranslated region Proteins 0.000 description 2
206010043561 Thrombocytopenic purpura Diseases 0.000 description 2
208000000323 Tourette Syndrome Diseases 0.000 description 2
208000016620 Tourette disease Diseases 0.000 description 2
101710150448 Transcriptional regulator Myc Proteins 0.000 description 2
208000026911 Tuberous sclerosis complex Diseases 0.000 description 2
201000006704 Ulcerative Colitis Diseases 0.000 description 2
DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
206010046851 Uveitis Diseases 0.000 description 2
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
206010046996 Varicose vein Diseases 0.000 description 2
206010047115 Vasculitis Diseases 0.000 description 2
206010047249 Venous thrombosis Diseases 0.000 description 2
108010067390 Viral Proteins Proteins 0.000 description 2
FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
229930003427 Vitamin E Natural products 0.000 description 2
208000027276 Von Willebrand disease Diseases 0.000 description 2
230000002159 abnormal effect Effects 0.000 description 2
230000005856 abnormality Effects 0.000 description 2
230000021736 acetylation Effects 0.000 description 2
238000006640 acetylation reaction Methods 0.000 description 2
229960001138 acetylsalicylic acid Drugs 0.000 description 2
208000013685 acquired idiopathic sideroblastic anemia Diseases 0.000 description 2
208000017733 acquired polycythemia vera Diseases 0.000 description 2
208000009621 actinic keratosis Diseases 0.000 description 2
229960000643 adenine Drugs 0.000 description 2
208000011341 adult acute respiratory distress syndrome Diseases 0.000 description 2
201000000028 adult respiratory distress syndrome Diseases 0.000 description 2
230000002411 adverse Effects 0.000 description 2
150000001298 alcohols Chemical class 0.000 description 2
150000001299 aldehydes Chemical class 0.000 description 2
125000001931 aliphatic group Chemical group 0.000 description 2
HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 2
231100000540 amenorrhea Toxicity 0.000 description 2
230000006986 amnesia Effects 0.000 description 2
206010002022 amyloidosis Diseases 0.000 description 2
206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 2
238000002399 angioplasty Methods 0.000 description 2
210000004102 animal cell Anatomy 0.000 description 2
230000003078 antioxidant effect Effects 0.000 description 2
239000000074 antisense oligonucleotide Substances 0.000 description 2
238000012230 antisense oligonucleotides Methods 0.000 description 2
230000036506 anxiety Effects 0.000 description 2
206010002906 aortic stenosis Diseases 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
206010003119 arrhythmia Diseases 0.000 description 2
230000006793 arrhythmia Effects 0.000 description 2
FZCSTZYAHCUGEM-UHFFFAOYSA-N aspergillomarasmine B Natural products OC(=O)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O FZCSTZYAHCUGEM-UHFFFAOYSA-N 0.000 description 2
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
201000008937 atopic dermatitis Diseases 0.000 description 2
201000000448 autoimmune hemolytic anemia Diseases 0.000 description 2
210000003719 b-lymphocyte Anatomy 0.000 description 2
201000009904 bacterial meningitis Diseases 0.000 description 2
208000018300 basal ganglia disease Diseases 0.000 description 2
208000021654 bicuspid aortic valve disease Diseases 0.000 description 2
239000003613 bile acid Substances 0.000 description 2
230000008827 biological function Effects 0.000 description 2
230000008236 biological pathway Effects 0.000 description 2
230000006696 biosynthetic metabolic pathway Effects 0.000 description 2
210000000625 blastula Anatomy 0.000 description 2
230000000903 blocking effect Effects 0.000 description 2
201000009267 bronchiectasis Diseases 0.000 description 2
230000002308 calcification Effects 0.000 description 2
230000000711 cancerogenic effect Effects 0.000 description 2
238000005251 capillar electrophoresis Methods 0.000 description 2
231100000315 carcinogenic Toxicity 0.000 description 2
208000005761 carcinoid heart disease Diseases 0.000 description 2
238000006555 catalytic reaction Methods 0.000 description 2
206010007776 catatonia Diseases 0.000 description 2
210000000170 cell membrane Anatomy 0.000 description 2
208000015114 central nervous system disease Diseases 0.000 description 2
206010008129 cerebral palsy Diseases 0.000 description 2
208000026106 cerebrovascular disease Diseases 0.000 description 2
238000007385 chemical modification Methods 0.000 description 2
201000001352 cholecystitis Diseases 0.000 description 2
208000003571 choroideremia Diseases 0.000 description 2
210000000349 chromosome Anatomy 0.000 description 2
208000016644 chronic atrophic gastritis Diseases 0.000 description 2
208000007451 chronic bronchitis Diseases 0.000 description 2
208000016532 chronic granulomatous disease Diseases 0.000 description 2
208000025302 chronic primary adrenal insufficiency Diseases 0.000 description 2
WDECIBYCCFPHNR-UHFFFAOYSA-N chrysene Chemical compound C1=CC=CC2=CC=C3C4=CC=CC=C4C=CC3=C21 WDECIBYCCFPHNR-UHFFFAOYSA-N 0.000 description 2
230000004087 circulation Effects 0.000 description 2
230000007882 cirrhosis Effects 0.000 description 2
208000019425 cirrhosis of liver Diseases 0.000 description 2
RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 2
239000005516 coenzyme A Substances 0.000 description 2
229940093530 coenzyme a Drugs 0.000 description 2
210000001072 colon Anatomy 0.000 description 2
238000012875 competitive assay Methods 0.000 description 2
238000004590 computer program Methods 0.000 description 2
208000028831 congenital heart disease Diseases 0.000 description 2
208000010247 contact dermatitis Diseases 0.000 description 2
210000004351 coronary vessel Anatomy 0.000 description 2
230000002596 correlated effect Effects 0.000 description 2
201000009805 cryptogenic organizing pneumonia Diseases 0.000 description 2
229960004397 cyclophosphamide Drugs 0.000 description 2
235000018417 cysteine Nutrition 0.000 description 2
210000000172 cytosol Anatomy 0.000 description 2
231100000599 cytotoxic agent Toxicity 0.000 description 2
230000003412 degenerative effect Effects 0.000 description 2
238000006731 degradation reaction Methods 0.000 description 2
KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 2
230000001496 desquamative effect Effects 0.000 description 2
208000016097 disease of metabolism Diseases 0.000 description 2
238000002224 dissection Methods 0.000 description 2
150000002019 disulfides Chemical class 0.000 description 2
208000010118 dystonia Diseases 0.000 description 2
239000012636 effector Substances 0.000 description 2
230000002124 endocrine Effects 0.000 description 2
230000002616 endonucleolytic effect Effects 0.000 description 2
150000002085 enols Chemical class 0.000 description 2
108700004025 env Genes Proteins 0.000 description 2
201000000165 epidural abscess Diseases 0.000 description 2
230000001667 episodic effect Effects 0.000 description 2
201000001155 extrinsic allergic alveolitis Diseases 0.000 description 2
210000001508 eye Anatomy 0.000 description 2
201000006061 fatal familial insomnia Diseases 0.000 description 2
208000001031 fetal erythroblastosis Diseases 0.000 description 2
239000012530 fluid Substances 0.000 description 2
238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
238000001476 gene delivery Methods 0.000 description 2
102000054767 gene variant Human genes 0.000 description 2
230000009395 genetic defect Effects 0.000 description 2
208000016361 genetic disease Diseases 0.000 description 2
235000013922 glutamic acid Nutrition 0.000 description 2
239000004220 glutamic acid Substances 0.000 description 2
210000000224 granular leucocyte Anatomy 0.000 description 2
230000012010 growth Effects 0.000 description 2
238000001631 haemodialysis Methods 0.000 description 2
230000036541 health Effects 0.000 description 2
208000019622 heart disease Diseases 0.000 description 2
208000018578 heart valve disease Diseases 0.000 description 2
230000000322 hemodialysis Effects 0.000 description 2
208000027700 hepatic dysfunction Diseases 0.000 description 2
208000006454 hepatitis Diseases 0.000 description 2
231100000283 hepatitis Toxicity 0.000 description 2
208000003215 hereditary nephritis Diseases 0.000 description 2
239000000710 homodimer Substances 0.000 description 2
229930195733 hydrocarbon Natural products 0.000 description 2
229910052739 hydrogen Inorganic materials 0.000 description 2
239000001257 hydrogen Substances 0.000 description 2
239000000852 hydrogen donor Substances 0.000 description 2
230000002209 hydrophobic effect Effects 0.000 description 2
208000022098 hypersensitivity pneumonitis Diseases 0.000 description 2
208000015210 hypertensive heart disease Diseases 0.000 description 2
230000001969 hypertrophic effect Effects 0.000 description 2
230000007954 hypoxia Effects 0.000 description 2
230000001900 immune effect Effects 0.000 description 2
230000036737 immune function Effects 0.000 description 2
238000011534 incubation Methods 0.000 description 2
230000002458 infectious effect Effects 0.000 description 2
201000007119 infective endocarditis Diseases 0.000 description 2
208000030603 inherited susceptibility to asthma Diseases 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
230000002452 interceptive effect Effects 0.000 description 2
208000036971 interstitial lung disease 2 Diseases 0.000 description 2
238000007917 intracranial administration Methods 0.000 description 2
208000002551 irritable bowel syndrome Diseases 0.000 description 2
230000000302 ischemic effect Effects 0.000 description 2
206010023497 kuru Diseases 0.000 description 2
208000006443 lactic acidosis Diseases 0.000 description 2
231100000518 lethal Toxicity 0.000 description 2
230000001665 lethal effect Effects 0.000 description 2
230000029226 lipidation Effects 0.000 description 2
IXAQOQZEOGMIQS-SSQFXEBMSA-N lipoxin A4 Chemical compound CCCCC[C@H](O)\C=C\C=C/C=C/C=C/[C@@H](O)[C@@H](O)CCCC(O)=O IXAQOQZEOGMIQS-SSQFXEBMSA-N 0.000 description 2
239000007788 liquid Substances 0.000 description 2
208000019423 liver disease Diseases 0.000 description 2
230000005976 liver dysfunction Effects 0.000 description 2
208000014018 liver neoplasm Diseases 0.000 description 2
201000003453 lung abscess Diseases 0.000 description 2
208000037841 lung tumor Diseases 0.000 description 2
210000004698 lymphocyte Anatomy 0.000 description 2
231100001023 lymphopenia Toxicity 0.000 description 2
239000006249 magnetic particle Substances 0.000 description 2
238000013507 mapping Methods 0.000 description 2
201000007261 marantic endocarditis Diseases 0.000 description 2
230000002503 metabolic effect Effects 0.000 description 2
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
208000005135 methemoglobinemia Diseases 0.000 description 2
238000000520 microinjection Methods 0.000 description 2
VKHAHZOOUSRJNA-GCNJZUOMSA-N mifepristone Chemical compound C1([C@@H]2C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]3CC[C@@]([C@]3(C2)C)(O)C#CC)=CC=C(N(C)C)C=C1 VKHAHZOOUSRJNA-GCNJZUOMSA-N 0.000 description 2
206010027599 migraine Diseases 0.000 description 2
235000013336 milk Nutrition 0.000 description 2
239000008267 milk Substances 0.000 description 2
210000004080 milk Anatomy 0.000 description 2
230000036651 mood Effects 0.000 description 2
208000005264 motor neuron disease Diseases 0.000 description 2
201000000585 muscular atrophy Diseases 0.000 description 2
238000002703 mutagenesis Methods 0.000 description 2
206010028537 myelofibrosis Diseases 0.000 description 2
230000002107 myocardial effect Effects 0.000 description 2
208000031225 myocardial ischemia Diseases 0.000 description 2
230000002151 myoclonic effect Effects 0.000 description 2
208000018389 neoplasm of cerebral hemisphere Diseases 0.000 description 2
210000005170 neoplastic cell Anatomy 0.000 description 2
210000000653 nervous system Anatomy 0.000 description 2
230000001537 neural effect Effects 0.000 description 2
201000004931 neurofibromatosis Diseases 0.000 description 2
208000018360 neuromuscular disease Diseases 0.000 description 2
210000000440 neutrophil Anatomy 0.000 description 2
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
208000016135 nonbacterial thrombotic endocarditis Diseases 0.000 description 2
235000020824 obesity Nutrition 0.000 description 2
206010030875 ophthalmoplegia Diseases 0.000 description 2
201000008482 osteoarthritis Diseases 0.000 description 2
230000004792 oxidative damage Effects 0.000 description 2
230000036542 oxidative stress Effects 0.000 description 2
230000003071 parasitic effect Effects 0.000 description 2
201000003045 paroxysmal nocturnal hemoglobinuria Diseases 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
239000002245 particle Substances 0.000 description 2
208000008494 pericarditis Diseases 0.000 description 2
208000029308 periodic paralysis Diseases 0.000 description 2
208000027232 peripheral nervous system disease Diseases 0.000 description 2
210000001322 periplasm Anatomy 0.000 description 2
201000008611 peroxisomal acyl-CoA oxidase deficiency Diseases 0.000 description 2
208000028591 pheochromocytoma Diseases 0.000 description 2
201000003437 pleural cancer Diseases 0.000 description 2
206010035653 pneumoconiosis Diseases 0.000 description 2
201000003144 pneumothorax Diseases 0.000 description 2
125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 description 2
208000037244 polycythemia vera Diseases 0.000 description 2
238000003752 polymerase chain reaction Methods 0.000 description 2
230000001323 posttranslational effect Effects 0.000 description 2
201000009395 primary hyperaldosteronism Diseases 0.000 description 2
PAHGJZDQXIOYTH-UHFFFAOYSA-N pristanic acid Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C(O)=O PAHGJZDQXIOYTH-UHFFFAOYSA-N 0.000 description 2
230000000750 progressive effect Effects 0.000 description 2
201000002212 progressive supranuclear palsy Diseases 0.000 description 2
230000004952 protein activity Effects 0.000 description 2
208000020016 psychiatric disease Diseases 0.000 description 2
201000003489 pulmonary alveolar proteinosis Diseases 0.000 description 2
208000005333 pulmonary edema Diseases 0.000 description 2
201000009732 pulmonary eosinophilia Diseases 0.000 description 2
201000003456 pulmonary hemosiderosis Diseases 0.000 description 2
208000002815 pulmonary hypertension Diseases 0.000 description 2
230000007575 pulmonary infarction Effects 0.000 description 2
208000008128 pulmonary tuberculosis Diseases 0.000 description 2
201000010108 pycnodysostosis Diseases 0.000 description 2
238000011002 quantification Methods 0.000 description 2
206010061928 radiculitis Diseases 0.000 description 2
208000002574 reactive arthritis Diseases 0.000 description 2
238000005215 recombination Methods 0.000 description 2
238000011084 recovery Methods 0.000 description 2
208000007260 recurrent myoglobinuria Diseases 0.000 description 2
238000006479 redox reaction Methods 0.000 description 2
230000000717 retained effect Effects 0.000 description 2
229960003471 retinol Drugs 0.000 description 2
235000020944 retinol Nutrition 0.000 description 2
239000011607 retinol Substances 0.000 description 2
201000003068 rheumatic fever Diseases 0.000 description 2
208000004124 rheumatic heart disease Diseases 0.000 description 2
201000000306 sarcoidosis Diseases 0.000 description 2
201000000980 schizophrenia Diseases 0.000 description 2
230000028327 secretion Effects 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
150000004666 short chain fatty acids Chemical class 0.000 description 2
208000007056 sickle cell anemia Diseases 0.000 description 2
239000007790 solid phase Substances 0.000 description 2
238000001356 surgical procedure Methods 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
230000002194 synthesizing effect Effects 0.000 description 2
230000008685 targeting Effects 0.000 description 2
239000005460 tetrahydrofolate Substances 0.000 description 2
229940124597 therapeutic agent Drugs 0.000 description 2
125000003396 thiol group Chemical group [H]S* 0.000 description 2
230000002537 thrombolytic effect Effects 0.000 description 2
230000001052 transient effect Effects 0.000 description 2
239000001226 triphosphate Substances 0.000 description 2
235000011178 triphosphate Nutrition 0.000 description 2
230000010415 tropism Effects 0.000 description 2
208000009999 tuberous sclerosis Diseases 0.000 description 2
208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
241001515965 unidentified phage Species 0.000 description 2
238000011144 upstream manufacturing Methods 0.000 description 2
229940035893 uracil Drugs 0.000 description 2
239000004474 valine Substances 0.000 description 2
208000027185 varicose disease Diseases 0.000 description 2
230000002792 vascular Effects 0.000 description 2
201000011531 vascular cancer Diseases 0.000 description 2
208000019553 vascular disease Diseases 0.000 description 2
206010055031 vascular neoplasm Diseases 0.000 description 2
230000009385 viral infection Effects 0.000 description 2
201000010044 viral meningitis Diseases 0.000 description 2
208000009421 viral pneumonia Diseases 0.000 description 2
239000013603 viral vector Substances 0.000 description 2
235000019155 vitamin A Nutrition 0.000 description 2
239000011719 vitamin A Substances 0.000 description 2
235000019165 vitamin E Nutrition 0.000 description 2
229940046009 vitamin E Drugs 0.000 description 2
239000011709 vitamin E Substances 0.000 description 2
229940045997 vitamin a Drugs 0.000 description 2
208000012137 von Willebrand disease (hereditary or acquired) Diseases 0.000 description 2
201000002928 xanthinuria Diseases 0.000 description 2
230000002034 xenobiotic effect Effects 0.000 description 2
QPUHWUSUBHNZCG-UWVGGRQHSA-N (1S,2S)-1,2-dihydronaphthalene-1,2-diol Chemical compound C1=CC=C2[C@H](O)[C@@H](O)C=CC2=C1 QPUHWUSUBHNZCG-UWVGGRQHSA-N 0.000 description 1
ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
VEEGZPWAAPPXRB-BJMVGYQFSA-N (3e)-3-(1h-imidazol-5-ylmethylidene)-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2\C1=C/C1=CN=CN1 VEEGZPWAAPPXRB-BJMVGYQFSA-N 0.000 description 1
LTHDIZOWAIGONP-KODRXGBYSA-N (3r,4s,5r)-3,4,5-trihydroxy-6-phosphonooxyhexanoic acid Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@H](O)CC(O)=O LTHDIZOWAIGONP-KODRXGBYSA-N 0.000 description 1
WRRSFOZOETZUPG-FFHNEAJVSA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;hydrate Chemical compound O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC WRRSFOZOETZUPG-FFHNEAJVSA-N 0.000 description 1
DWAKNKKXGALPNW-BYPYZUCNSA-N (S)-1-pyrroline-5-carboxylic acid Chemical compound OC(=O)[C@@H]1CCC=N1 DWAKNKKXGALPNW-BYPYZUCNSA-N 0.000 description 1
102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 1
150000005206 1,2-dihydroxybenzenes Chemical class 0.000 description 1
AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical class O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
102100024341 10 kDa heat shock protein, mitochondrial Human genes 0.000 description 1
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
KMQGFEBCBYXSPZ-OABWHSJTSA-N 15-oxolipoxin A4 Chemical compound CCCCCC(=O)\C=C\C=C/C=C/C=C/[C@@H](O)[C@@H](O)CCCC(O)=O KMQGFEBCBYXSPZ-OABWHSJTSA-N 0.000 description 1
UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 1
PFCLMNDDPTZJHQ-XLPZGREQSA-N 2-amino-7-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1h-pyrrolo[2,3-d]pyrimidin-4-one Chemical compound C1=CC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 PFCLMNDDPTZJHQ-XLPZGREQSA-N 0.000 description 1
LZZOARFGFBWHAV-FAOVPRGRSA-N 2-hydroxyethyl(trimethyl)azanium;methanol;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC.C[N+](C)(C)CCO.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O LZZOARFGFBWHAV-FAOVPRGRSA-N 0.000 description 1
PMWATMXOQQZNBX-DKBZLLMOSA-N 2-methylcrotonoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C(/C)=C/C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 PMWATMXOQQZNBX-DKBZLLMOSA-N 0.000 description 1
108700020831 3-Hydroxyacyl-CoA Dehydrogenase Proteins 0.000 description 1
108700005239 3-Hydroxyacyl-CoA Dehydrogenase Deficiency Proteins 0.000 description 1
PIIZYNQECPTVEO-UHFFFAOYSA-N 4-nitro-m-cresol Chemical compound CC1=CC(O)=CC=C1[N+]([O-])=O PIIZYNQECPTVEO-UHFFFAOYSA-N 0.000 description 1
GOHBXWHNJHENRX-UHFFFAOYSA-N 5-Methylchrysene Chemical compound C1=CC=CC2=C3C(C)=CC4=CC=CC=C4C3=CC=C21 GOHBXWHNJHENRX-UHFFFAOYSA-N 0.000 description 1
LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 1
101710159080 Aconitate hydratase A Proteins 0.000 description 1
101710159078 Aconitate hydratase B Proteins 0.000 description 1
108010024223 Adenine phosphoribosyltransferase Proteins 0.000 description 1
CXISPYVYMQWFLE-VKHMYHEASA-N Ala-Gly Chemical compound C[C@H]([NH3+])C(=O)NCC([O-])=O CXISPYVYMQWFLE-VKHMYHEASA-N 0.000 description 1
102000016912 Aldehyde Reductase Human genes 0.000 description 1
102000018518 Aldehyde dehydrogenase domains Human genes 0.000 description 1
108050007629 Aldehyde dehydrogenase domains Proteins 0.000 description 1
108010053754 Aldehyde reductase Proteins 0.000 description 1
102000005602 Aldo-Keto Reductases Human genes 0.000 description 1
108010084469 Aldo-Keto Reductases Proteins 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
108700028369 Alleles Proteins 0.000 description 1
102100024085 Alpha-aminoadipic semialdehyde dehydrogenase Human genes 0.000 description 1
240000005369 Alstonia scholaris Species 0.000 description 1
108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
108090001008 Avidin Proteins 0.000 description 1
244000063299 Bacillus subtilis Species 0.000 description 1
235000014469 Bacillus subtilis Nutrition 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
OGBVRMYSNSKIEF-UHFFFAOYSA-N Benzylphosphonic acid Chemical class OP(O)(=O)CC1=CC=CC=C1 OGBVRMYSNSKIEF-UHFFFAOYSA-N 0.000 description 1
KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
108010049668 Betaine-Aldehyde Dehydrogenase Proteins 0.000 description 1
208000033258 Bifunctional enzyme deficiency Diseases 0.000 description 1
101000800130 Bos taurus Thyroglobulin Proteins 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
241000186311 Brevibacterium sterolicum Species 0.000 description 1
238000011740 C57BL/6 mouse Methods 0.000 description 1
210000004366 CD4-positive T-lymphocyte Anatomy 0.000 description 1
241000244203 Caenorhabditis elegans Species 0.000 description 1
101100122788 Caenorhabditis elegans gpx-2 gene Proteins 0.000 description 1
101100122801 Caenorhabditis elegans gpx-3 gene Proteins 0.000 description 1
101100152433 Caenorhabditis elegans tat-1 gene Proteins 0.000 description 1
241000173351 Camvirus Species 0.000 description 1
241000222122 Candida albicans Species 0.000 description 1
241000283707 Capra Species 0.000 description 1
102000014914 Carrier Proteins Human genes 0.000 description 1
108010078791 Carrier Proteins Proteins 0.000 description 1
241000701489 Cauliflower mosaic virus Species 0.000 description 1
108010012236 Chemokines Proteins 0.000 description 1
102000019034 Chemokines Human genes 0.000 description 1
239000005496 Chlorsulfuron Substances 0.000 description 1
108010089254 Cholesterol oxidase Proteins 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
241000186216 Corynebacterium Species 0.000 description 1
208000020406 Creutzfeldt Jacob disease Diseases 0.000 description 1
208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 description 1
208000010859 Creutzfeldt-Jakob disease Diseases 0.000 description 1
241000192700 Cyanobacteria Species 0.000 description 1
102000010907 Cyclooxygenase 2 Human genes 0.000 description 1
108010037462 Cyclooxygenase 2 Proteins 0.000 description 1
UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
102100039077 Cytosolic 10-formyltetrahydrofolate dehydrogenase Human genes 0.000 description 1
102100028712 Cytosolic purine 5'-nucleotidase Human genes 0.000 description 1
IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 description 1
CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
SBJKKFFYIZUCET-UHFFFAOYSA-N Dehydroascorbic acid Natural products OCC(O)C1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-UHFFFAOYSA-N 0.000 description 1
241000192091 Deinococcus radiodurans Species 0.000 description 1
101710129849 Delta-1-pyrroline-5-carboxylate dehydrogenase Proteins 0.000 description 1
102100022283 Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial Human genes 0.000 description 1
241000702421 Dependoparvovirus Species 0.000 description 1
208000002249 Diabetes Complications Diseases 0.000 description 1
206010012655 Diabetic complications Diseases 0.000 description 1
108010028127 Dihydrolipoamide Dehydrogenase Proteins 0.000 description 1
102000028526 Dihydrolipoamide Dehydrogenase Human genes 0.000 description 1
101710090144 Dihydrolipoyl dehydrogenase Proteins 0.000 description 1
102100023319 Dihydrolipoyl dehydrogenase, mitochondrial Human genes 0.000 description 1
MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
108010042091 Dodecenoyl-CoA Isomerase Proteins 0.000 description 1
102000004334 Dodecenoyl-CoA Isomerase Human genes 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
102000012737 Electron-Transferring Flavoproteins Human genes 0.000 description 1
108010079426 Electron-Transferring Flavoproteins Proteins 0.000 description 1
102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 1
108010042407 Endonucleases Proteins 0.000 description 1
102000004533 Endonucleases Human genes 0.000 description 1
241000701867 Enterobacteria phage T7 Species 0.000 description 1
101710091045 Envelope protein Proteins 0.000 description 1
241000283086 Equidae Species 0.000 description 1
241000283073 Equus caballus Species 0.000 description 1
108091029865 Exogenous DNA Proteins 0.000 description 1
108060002716 Exonuclease Proteins 0.000 description 1
108091060211 Expressed sequence tag Proteins 0.000 description 1
108010054218 Factor VIII Proteins 0.000 description 1
102000001690 Factor VIII Human genes 0.000 description 1
201000003542 Factor VIII deficiency Diseases 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
229930091371 Fructose Natural products 0.000 description 1
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
239000005715 Fructose Substances 0.000 description 1
206010017533 Fungal infection Diseases 0.000 description 1
241000233866 Fungi Species 0.000 description 1
SAEBUDRWKUXLOM-ACZMJKKPSA-N Glu-Cys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(O)=O SAEBUDRWKUXLOM-ACZMJKKPSA-N 0.000 description 1
QXDXIXFSFHUYAX-MNXVOIDGSA-N Glu-Ile-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(O)=O QXDXIXFSFHUYAX-MNXVOIDGSA-N 0.000 description 1
CBEUFCJRFNZMCU-SRVKXCTJSA-N Glu-Met-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O CBEUFCJRFNZMCU-SRVKXCTJSA-N 0.000 description 1
108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 1
108010015776 Glucose oxidase Proteins 0.000 description 1
239000004366 Glucose oxidase Substances 0.000 description 1
102000001803 Glucose-methanol-choline oxidoreductases Human genes 0.000 description 1
108050009034 Glucose-methanol-choline oxidoreductases Proteins 0.000 description 1
102000002794 Glucosephosphate Dehydrogenase Human genes 0.000 description 1
108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
102000053187 Glucuronidase Human genes 0.000 description 1
108010060309 Glucuronidase Proteins 0.000 description 1
108010015451 Glutaryl-CoA Dehydrogenase Proteins 0.000 description 1
102100028603 Glutaryl-CoA dehydrogenase, mitochondrial Human genes 0.000 description 1
108010063907 Glutathione Reductase Proteins 0.000 description 1
102100036442 Glutathione reductase, mitochondrial Human genes 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
108010043428 Glycine hydroxymethyltransferase Proteins 0.000 description 1
108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
241000606768 Haemophilus influenzae Species 0.000 description 1
208000031220 Hemophilia Diseases 0.000 description 1
206010019695 Hepatic neoplasm Diseases 0.000 description 1
208000005176 Hepatitis C Diseases 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
WZOGEMJIZBNFBK-CIUDSAMLSA-N His-Asp-Asn Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O WZOGEMJIZBNFBK-CIUDSAMLSA-N 0.000 description 1
SDTPKSOWFXBACN-GUBZILKMSA-N His-Glu-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O SDTPKSOWFXBACN-GUBZILKMSA-N 0.000 description 1
YADRBUZBKHHDAO-XPUUQOCRSA-N His-Gly-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](C)C(O)=O YADRBUZBKHHDAO-XPUUQOCRSA-N 0.000 description 1
101000717967 Homo sapiens Aldehyde dehydrogenase family 3 member A2 Proteins 0.000 description 1
101001041673 Homo sapiens Peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing] Proteins 0.000 description 1
108090000144 Human Proteins Proteins 0.000 description 1
102000003839 Human Proteins Human genes 0.000 description 1
241000700588 Human alphaherpesvirus 1 Species 0.000 description 1
101001042049 Human herpesvirus 1 (strain 17) Transcriptional regulator ICP22 Proteins 0.000 description 1
101000999690 Human herpesvirus 2 (strain HG52) E3 ubiquitin ligase ICP22 Proteins 0.000 description 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
108010020056 Hydrogenase Proteins 0.000 description 1
208000035150 Hypercholesterolemia Diseases 0.000 description 1
206010021118 Hypotonia Diseases 0.000 description 1
101150027427 ICP4 gene Proteins 0.000 description 1
USXAYNCLFSUSBA-MGHWNKPDSA-N Ile-Phe-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N USXAYNCLFSUSBA-MGHWNKPDSA-N 0.000 description 1
108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
208000032754 Infant Death Diseases 0.000 description 1
208000008498 Infantile Refsum disease Diseases 0.000 description 1
208000022559 Inflammatory bowel disease Diseases 0.000 description 1
108020005350 Initiator Codon Proteins 0.000 description 1
229930010555 Inosine Natural products 0.000 description 1
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
102100034349 Integrase Human genes 0.000 description 1
108010025815 Kanamycin Kinase Proteins 0.000 description 1
206010048804 Kearns-Sayre syndrome Diseases 0.000 description 1
229930194542 Keto Natural products 0.000 description 1
241000588747 Klebsiella pneumoniae Species 0.000 description 1
241000235058 Komagataella pastoris Species 0.000 description 1
108010009384 L-Iditol 2-Dehydrogenase Proteins 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
KABXUUFDPUOJMW-BYPYZUCNSA-N L-glutamic 5-semialdehyde Chemical compound OC(=O)[C@@H](N)CCC=O KABXUUFDPUOJMW-BYPYZUCNSA-N 0.000 description 1
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
108700005090 Lethal Genes Proteins 0.000 description 1
108010058996 Long-chain-aldehyde dehydrogenase Proteins 0.000 description 1
108060001084 Luciferase Proteins 0.000 description 1
239000005089 Luciferase Substances 0.000 description 1
DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
108010062166 Lys-Asn-Asp Proteins 0.000 description 1
BYPMOIFBQPEWOH-CIUDSAMLSA-N Lys-Asn-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N BYPMOIFBQPEWOH-CIUDSAMLSA-N 0.000 description 1
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
208000024556 Mendelian disease Diseases 0.000 description 1
108090000112 Mercury(II) reductases Proteins 0.000 description 1
101100261636 Methanothermobacter marburgensis (strain ATCC BAA-927 / DSM 2133 / JCM 14651 / NBRC 100331 / OCM 82 / Marburg) trpB2 gene Proteins 0.000 description 1
101000717965 Mus musculus Aldehyde dehydrogenase, dimeric NADP-preferring Proteins 0.000 description 1
208000007379 Muscle Hypotonia Diseases 0.000 description 1
208000010428 Muscle Weakness Diseases 0.000 description 1
206010028372 Muscular weakness Diseases 0.000 description 1
208000031888 Mycoses Diseases 0.000 description 1
KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
101710197978 NADPH-dependent oxidoreductase Proteins 0.000 description 1
229930193140 Neomycin Natural products 0.000 description 1
208000008457 Neurologic Manifestations Diseases 0.000 description 1
ATCICVFRSJQYDV-DDRHJXQASA-N Neurosporene Natural products C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/CC/C=C(\CC/C=C(\C)/C)/C)\C)/C)\C)(\C=C\C=C(/CC/C=C(\C)/C)\C)/C ATCICVFRSJQYDV-DDRHJXQASA-N 0.000 description 1
108020004485 Nonsense Codon Proteins 0.000 description 1
108091005461 Nucleic proteins Chemical group 0.000 description 1
108010011356 Nucleoside phosphotransferase Proteins 0.000 description 1
208000011623 Obstructive Lung disease Diseases 0.000 description 1
108020005187 Oligonucleotide Probes Proteins 0.000 description 1
238000009004 PCR Kit Methods 0.000 description 1
241000526686 Paracoccidioides brasiliensis Species 0.000 description 1
102000057297 Pepsin A Human genes 0.000 description 1
108090000284 Pepsin A Proteins 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
108010067902 Peptide Library Proteins 0.000 description 1
102100021404 Peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing] Human genes 0.000 description 1
108010085186 Peroxisomal Targeting Signals Proteins 0.000 description 1
208000037581 Persistent Infection Diseases 0.000 description 1
102000015082 Phosphoribosylglycinamide formyltransferase Human genes 0.000 description 1
108010064209 Phosphoribosylglycinamide formyltransferase Proteins 0.000 description 1
102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
241000235648 Pichia Species 0.000 description 1
241000223960 Plasmodium falciparum Species 0.000 description 1
241000881705 Porcine endogenous retrovirus Species 0.000 description 1
241000288906 Primates Species 0.000 description 1
239000004365 Protease Substances 0.000 description 1
101710188315 Protein X Proteins 0.000 description 1
108030003943 Protein-disulfide reductases Proteins 0.000 description 1
206010037075 Protozoal infections Diseases 0.000 description 1
241000589781 Pseudomonas oleovorans Species 0.000 description 1
206010037714 Quadriplegia Diseases 0.000 description 1
102000044126 RNA-Binding Proteins Human genes 0.000 description 1
101710105008 RNA-binding protein Proteins 0.000 description 1
101000717971 Rattus norvegicus Aldehyde dehydrogenase family 3 member A2 Proteins 0.000 description 1
101000896035 Rattus norvegicus Enoyl-CoA hydratase, mitochondrial Proteins 0.000 description 1
101100231693 Rattus norvegicus Hpgds gene Proteins 0.000 description 1
101000579918 Rattus norvegicus Peroxisomal trans-2-enoyl-CoA reductase Proteins 0.000 description 1
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
108091007187 Reductases Proteins 0.000 description 1
108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
108700008625 Reporter Genes Proteins 0.000 description 1
208000003826 Respiratory Acidosis Diseases 0.000 description 1
AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
108010041388 Ribonucleotide Reductases Proteins 0.000 description 1
102000000505 Ribonucleotide Reductases Human genes 0.000 description 1
108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 1
241000235347 Schizosaccharomyces pombe Species 0.000 description 1
108010074686 Selenoproteins Proteins 0.000 description 1
102000008114 Selenoproteins Human genes 0.000 description 1
108091081021 Sense strand Proteins 0.000 description 1
VQBLHWSPVYYZTB-DCAQKATOSA-N Ser-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)N VQBLHWSPVYYZTB-DCAQKATOSA-N 0.000 description 1
CDVFZMOFNJPUDD-ACZMJKKPSA-N Ser-Gln-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O CDVFZMOFNJPUDD-ACZMJKKPSA-N 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
102100021225 Serine hydroxymethyltransferase, cytosolic Human genes 0.000 description 1
208000036623 Severe mental retardation Diseases 0.000 description 1
241000607762 Shigella flexneri Species 0.000 description 1
208000020221 Short stature Diseases 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
102100026974 Sorbitol dehydrogenase Human genes 0.000 description 1
241000519995 Stachys sylvatica Species 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
102000007451 Steroid Receptors Human genes 0.000 description 1
108010085012 Steroid Receptors Proteins 0.000 description 1
244000057717 Streptococcus lactis Species 0.000 description 1
235000014897 Streptococcus lactis Nutrition 0.000 description 1
241000187747 Streptomyces Species 0.000 description 1
101100373395 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) xyoA gene Proteins 0.000 description 1
108010084086 Succinate-Semialdehyde Dehydrogenase Proteins 0.000 description 1
102100023673 Succinate-semialdehyde dehydrogenase, mitochondrial Human genes 0.000 description 1
208000034972 Sudden Infant Death Diseases 0.000 description 1
206010042440 Sudden infant death syndrome Diseases 0.000 description 1
108010006785 Taq Polymerase Proteins 0.000 description 1
108020005038 Terminator Codon Proteins 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
101710167005 Thiol:disulfide interchange protein DsbD Proteins 0.000 description 1
RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
ZMYCLHFLHRVOEA-HEIBUPTGSA-N Thr-Thr-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ZMYCLHFLHRVOEA-HEIBUPTGSA-N 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
102100033504 Thyroglobulin Human genes 0.000 description 1
ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
108700009124 Transcription Initiation Site Proteins 0.000 description 1
241000209140 Triticum Species 0.000 description 1
235000021307 Triticum Nutrition 0.000 description 1
SWSUXOKZKQRADK-FDARSICLSA-N Trp-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N SWSUXOKZKQRADK-FDARSICLSA-N 0.000 description 1
241000223105 Trypanosoma brucei Species 0.000 description 1
241000223109 Trypanosoma cruzi Species 0.000 description 1
KWKJGBHDYJOVCR-SRVKXCTJSA-N Tyr-Ser-Cys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N)O KWKJGBHDYJOVCR-SRVKXCTJSA-N 0.000 description 1
AFWXOGHZEKARFH-ACRUOGEOSA-N Tyr-Tyr-His Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CC=C(O)C=C1 AFWXOGHZEKARFH-ACRUOGEOSA-N 0.000 description 1
108091023045 Untranslated Region Proteins 0.000 description 1
GVJUTBOZZBTBIG-AVGNSLFASA-N Val-Lys-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N GVJUTBOZZBTBIG-AVGNSLFASA-N 0.000 description 1
LZRWTJSPTJSWDN-FKBYEOEOSA-N Val-Trp-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)N LZRWTJSPTJSWDN-FKBYEOEOSA-N 0.000 description 1
206010072656 Very long-chain acyl-coenzyme A dehydrogenase deficiency Diseases 0.000 description 1
IXKSXJFAGXLQOQ-XISFHERQSA-N WHWLQLKPGQPMY Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 IXKSXJFAGXLQOQ-XISFHERQSA-N 0.000 description 1
208000008383 Wilms tumor Diseases 0.000 description 1
PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
AEOBEOJCBAYXBA-KQYNXXCUSA-N [(2r,3r,4r,5r)-2-(6-aminopurin-9-yl)-4-hydroxy-5-(phosphonooxymethyl)oxolan-3-yl] dihydrogen phosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1OP(O)(O)=O AEOBEOJCBAYXBA-KQYNXXCUSA-N 0.000 description 1
230000001133 acceleration Effects 0.000 description 1
108020002494 acetyltransferase Proteins 0.000 description 1
102000005421 acetyltransferase Human genes 0.000 description 1
239000002253 acid Substances 0.000 description 1
208000037919 acquired disease Diseases 0.000 description 1
230000009471 action Effects 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
239000008186 active pharmaceutical agent Substances 0.000 description 1
239000013543 active substance Substances 0.000 description 1
125000002015 acyclic group Chemical group 0.000 description 1
125000002252 acyl group Chemical group 0.000 description 1
230000010933 acylation Effects 0.000 description 1
238000005917 acylation reaction Methods 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
OQIQSTLJSLGHID-WNWIJWBNSA-N aflatoxin B1 Chemical compound C=1([C@@H]2C=CO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O OQIQSTLJSLGHID-WNWIJWBNSA-N 0.000 description 1
238000011256 aggressive treatment Methods 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
108010047495 alanylglycine Proteins 0.000 description 1
108010070944 alanylhistidine Proteins 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
208000026935 allergic disease Diseases 0.000 description 1
230000003281 allosteric effect Effects 0.000 description 1
239000012637 allosteric effector Substances 0.000 description 1
230000004075 alteration Effects 0.000 description 1
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
229940126575 aminoglycoside Drugs 0.000 description 1
239000004037 angiogenesis inhibitor Substances 0.000 description 1
229940121369 angiogenesis inhibitor Drugs 0.000 description 1
235000010208 anthocyanin Nutrition 0.000 description 1
239000004410 anthocyanin Substances 0.000 description 1
229930002877 anthocyanin Natural products 0.000 description 1
150000004636 anthocyanins Chemical class 0.000 description 1
230000000340 anti-metabolite Effects 0.000 description 1
229940100197 antimetabolite Drugs 0.000 description 1
239000002256 antimetabolite Substances 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
230000006851 antioxidant defense Effects 0.000 description 1
235000006708 antioxidants Nutrition 0.000 description 1
230000006907 apoptotic process Effects 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
150000003934 aromatic aldehydes Chemical class 0.000 description 1
150000001491 aromatic compounds Chemical class 0.000 description 1
210000001106 artificial yeast chromosome Anatomy 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
244000052616 bacterial pathogen Species 0.000 description 1
108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 1
239000011324 bead Substances 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
229960003237 betaine Drugs 0.000 description 1
238000004166 bioassay Methods 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
238000001574 biopsy Methods 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
230000036983 biotransformation Effects 0.000 description 1
230000017531 blood circulation Effects 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
210000005013 brain tissue Anatomy 0.000 description 1
210000000069 breast epithelial cell Anatomy 0.000 description 1
238000009395 breeding Methods 0.000 description 1
230000001488 breeding effect Effects 0.000 description 1
239000000872 buffer Substances 0.000 description 1
244000309464 bull Species 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
229940095731 candida albicans Drugs 0.000 description 1
230000021523 carboxylation Effects 0.000 description 1
238000006473 carboxylation reaction Methods 0.000 description 1
150000001735 carboxylic acids Chemical class 0.000 description 1
210000004413 cardiac myocyte Anatomy 0.000 description 1
201000011529 cardiovascular cancer Diseases 0.000 description 1
150000001746 carotenes Chemical class 0.000 description 1
235000005473 carotenes Nutrition 0.000 description 1
239000000969 carrier Substances 0.000 description 1
230000006652 catabolic pathway Effects 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
230000032823 cell division Effects 0.000 description 1
230000007910 cell fusion Effects 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
230000006037 cell lysis Effects 0.000 description 1
230000003833 cell viability Effects 0.000 description 1
210000004671 cell-free system Anatomy 0.000 description 1
230000019522 cellular metabolic process Effects 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
235000010980 cellulose Nutrition 0.000 description 1
239000013522 chelant Substances 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
150000005829 chemical entities Chemical class 0.000 description 1
239000005081 chemiluminescent agent Substances 0.000 description 1
VJYIFXVZLXQVHO-UHFFFAOYSA-N chlorsulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)Cl)=N1 VJYIFXVZLXQVHO-UHFFFAOYSA-N 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
208000037976 chronic inflammation Diseases 0.000 description 1
230000006020 chronic inflammation Effects 0.000 description 1
OVSVTCFNLSGAMM-KGBODLQUSA-N cis-phytofluene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/C=C/C=C(C)/CCC=C(/C)CCC=C(C)C)C)C)C)C OVSVTCFNLSGAMM-KGBODLQUSA-N 0.000 description 1
239000013599 cloning vector Substances 0.000 description 1
229960004126 codeine Drugs 0.000 description 1
OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Natural products C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 1
239000005515 coenzyme Substances 0.000 description 1
208000029742 colonic neoplasm Diseases 0.000 description 1
238000002648 combination therapy Methods 0.000 description 1
230000009137 competitive binding Effects 0.000 description 1
239000013068 control sample Substances 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
238000009402 cross-breeding Methods 0.000 description 1
UHDGCWIWMRVCDJ-XVFCMESISA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-XVFCMESISA-N 0.000 description 1
210000000805 cytoplasm Anatomy 0.000 description 1
DAEAPNUQQAICNR-RRKCRQDMSA-K dADP(3-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP([O-])(=O)OP([O-])([O-])=O)O1 DAEAPNUQQAICNR-RRKCRQDMSA-K 0.000 description 1
FTDHDKPUHBLBTL-SHYZEUOFSA-K dCDP(3-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 FTDHDKPUHBLBTL-SHYZEUOFSA-K 0.000 description 1
CIKGWCTVFSRMJU-KVQBGUIXSA-N dGDP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O1 CIKGWCTVFSRMJU-KVQBGUIXSA-N 0.000 description 1
QHWZTVCCBMIIKE-SHYZEUOFSA-K dUDP(3-) Chemical compound O1[C@H](COP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 QHWZTVCCBMIIKE-SHYZEUOFSA-K 0.000 description 1
230000009849 deactivation Effects 0.000 description 1
230000009615 deamination Effects 0.000 description 1
238000006481 deamination reaction Methods 0.000 description 1
230000034994 death Effects 0.000 description 1
230000007123 defense Effects 0.000 description 1
230000000593 degrading effect Effects 0.000 description 1
235000020960 dehydroascorbic acid Nutrition 0.000 description 1
239000011615 dehydroascorbic acid Substances 0.000 description 1
238000002716 delivery method Methods 0.000 description 1
238000013461 design Methods 0.000 description 1
239000003599 detergent Substances 0.000 description 1
230000001627 detrimental effect Effects 0.000 description 1
230000029087 digestion Effects 0.000 description 1
108010017219 dihydrodiol dehydrogenases Proteins 0.000 description 1
239000000539 dimer Substances 0.000 description 1
XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
229960002986 dinoprostone Drugs 0.000 description 1
229940042396 direct acting antivirals thiosemicarbazones Drugs 0.000 description 1
238000010494 dissociation reaction Methods 0.000 description 1
230000005593 dissociations Effects 0.000 description 1
238000009826 distribution Methods 0.000 description 1
VZFRNCSOCOPNDB-UHFFFAOYSA-N domoic acid Natural products OC(=O)C(C)C=CC=C(C)C1CNC(C(O)=O)C1CC(O)=O VZFRNCSOCOPNDB-UHFFFAOYSA-N 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
239000000890 drug combination Substances 0.000 description 1
238000009510 drug design Methods 0.000 description 1
241001493065 dsRNA viruses Species 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
230000004064 dysfunction Effects 0.000 description 1
108010046025 early pregnancy factor Proteins 0.000 description 1
239000012039 electrophile Substances 0.000 description 1
238000004520 electroporation Methods 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
210000001900 endoderm Anatomy 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
238000001976 enzyme digestion Methods 0.000 description 1
230000029142 excretion Effects 0.000 description 1
102000013165 exonuclease Human genes 0.000 description 1
239000013613 expression plasmid Substances 0.000 description 1
229960000301 factor viii Drugs 0.000 description 1
230000004720 fertilization Effects 0.000 description 1
239000000835 fiber Substances 0.000 description 1
230000009969 flowable effect Effects 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
238000013467 fragmentation Methods 0.000 description 1
238000006062 fragmentation reaction Methods 0.000 description 1
235000021588 free fatty acids Nutrition 0.000 description 1
230000004927 fusion Effects 0.000 description 1
210000001156 gastric mucosa Anatomy 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
210000004602 germ cell Anatomy 0.000 description 1
239000011521 glass Substances 0.000 description 1
229940116332 glucose oxidase Drugs 0.000 description 1
235000019420 glucose oxidase Nutrition 0.000 description 1
229930195712 glutamate Natural products 0.000 description 1
125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
108010040856 glutamyl-cysteinyl-alanine Proteins 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
239000010931 gold Substances 0.000 description 1
210000003714 granulocyte Anatomy 0.000 description 1
239000005090 green fluorescent protein Substances 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
150000003278 haem Chemical class 0.000 description 1
230000003394 haemopoietic effect Effects 0.000 description 1
230000009931 harmful effect Effects 0.000 description 1
208000009429 hemophilia B Diseases 0.000 description 1
208000007386 hepatic encephalopathy Diseases 0.000 description 1
208000002672 hepatitis B Diseases 0.000 description 1
206010073071 hepatocellular carcinoma Diseases 0.000 description 1
230000002363 herbicidal effect Effects 0.000 description 1
239000004009 herbicide Substances 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
210000003917 human chromosome Anatomy 0.000 description 1
235000003642 hunger Nutrition 0.000 description 1
150000004677 hydrates Chemical class 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
150000002432 hydroperoxides Chemical class 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
230000003345 hyperglycaemic effect Effects 0.000 description 1
206010021198 ichthyosis Diseases 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
208000026278 immune system disease Diseases 0.000 description 1
230000016784 immunoglobulin production Effects 0.000 description 1
230000004957 immunoregulator effect Effects 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
238000000126 in silico method Methods 0.000 description 1
230000006698 induction Effects 0.000 description 1
230000001524 infective effect Effects 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
229960003786 inosine Drugs 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
230000010354 integration Effects 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
244000000056 intracellular parasite Species 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
238000007913 intrathecal administration Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
238000007914 intraventricular administration Methods 0.000 description 1
238000007852 inverse PCR Methods 0.000 description 1
230000005865 ionizing radiation Effects 0.000 description 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
229960000310 isoleucine Drugs 0.000 description 1
UYVZIWWBJMYRCD-ZMHDXICWSA-N isovaleryl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(C)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 UYVZIWWBJMYRCD-ZMHDXICWSA-N 0.000 description 1
230000003780 keratinization Effects 0.000 description 1
125000000468 ketone group Chemical group 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 1
210000003292 kidney cell Anatomy 0.000 description 1
230000002147 killing effect Effects 0.000 description 1
101150066555 lacZ gene Proteins 0.000 description 1
230000003859 lipid peroxidation Effects 0.000 description 1
238000001638 lipofection Methods 0.000 description 1
210000002311 liver mitochondria Anatomy 0.000 description 1
210000005228 liver tissue Anatomy 0.000 description 1
238000011068 loading method Methods 0.000 description 1
230000004807 localization Effects 0.000 description 1
230000007774 longterm Effects 0.000 description 1
235000012661 lycopene Nutrition 0.000 description 1
229960004999 lycopene Drugs 0.000 description 1
239000001751 lycopene Substances 0.000 description 1
OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
239000006166 lysate Substances 0.000 description 1
125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
230000002101 lytic effect Effects 0.000 description 1
101710130522 mRNA export factor Proteins 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
230000005291 magnetic effect Effects 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
230000031852 maintenance of location in cell Effects 0.000 description 1
210000001161 mammalian embryo Anatomy 0.000 description 1
238000005259 measurement Methods 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
210000004779 membrane envelope Anatomy 0.000 description 1
108010056360 mercuric reductase Proteins 0.000 description 1
210000003716 mesoderm Anatomy 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
229960000485 methotrexate Drugs 0.000 description 1
YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical class CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
239000011859 microparticle Substances 0.000 description 1
230000003228 microsomal effect Effects 0.000 description 1
229960003248 mifepristone Drugs 0.000 description 1
239000011707 mineral Substances 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
210000001700 mitochondrial membrane Anatomy 0.000 description 1
238000000329 molecular dynamics simulation Methods 0.000 description 1
239000000178 monomer Substances 0.000 description 1
238000010172 mouse model Methods 0.000 description 1
238000002887 multiple sequence alignment Methods 0.000 description 1
230000000869 mutational effect Effects 0.000 description 1
210000004165 myocardium Anatomy 0.000 description 1
229930014626 natural product Natural products 0.000 description 1
239000006225 natural substrate Substances 0.000 description 1
229960004927 neomycin Drugs 0.000 description 1
210000003061 neural cell Anatomy 0.000 description 1
230000017511 neuron migration Effects 0.000 description 1
235000008665 neurosporene Nutrition 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
239000002547 new drug Substances 0.000 description 1
230000037434 nonsense mutation Effects 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
231100000956 nontoxicity Toxicity 0.000 description 1
238000007899 nucleic acid hybridization Methods 0.000 description 1
239000002777 nucleoside Substances 0.000 description 1
230000000414 obstructive effect Effects 0.000 description 1
239000003921 oil Substances 0.000 description 1
239000002751 oligonucleotide probe Substances 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
210000003463 organelle Anatomy 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
238000012261 overproduction Methods 0.000 description 1
238000005895 oxidative decarboxylation reaction Methods 0.000 description 1
230000001590 oxidative effect Effects 0.000 description 1
YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 description 1
244000045947 parasite Species 0.000 description 1
244000052769 pathogen Species 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
239000013610 patient sample Substances 0.000 description 1
230000006320 pegylation Effects 0.000 description 1
230000035515 penetration Effects 0.000 description 1
230000004108 pentose phosphate pathway Effects 0.000 description 1
229940111202 pepsin Drugs 0.000 description 1
238000010647 peptide synthesis reaction Methods 0.000 description 1
230000003836 peripheral circulation Effects 0.000 description 1
230000003617 peroxidasic effect Effects 0.000 description 1
239000000575 pesticide Substances 0.000 description 1
210000001539 phagocyte Anatomy 0.000 description 1
239000012071 phase Substances 0.000 description 1
HTYIXCKSEQQCJO-UHFFFAOYSA-N phenaglycodol Chemical compound CC(C)(O)C(C)(O)C1=CC=C(Cl)C=C1 HTYIXCKSEQQCJO-UHFFFAOYSA-N 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
BQVCCPGCDUSGOE-UHFFFAOYSA-N phenylarsine oxide Chemical compound O=[As]C1=CC=CC=C1 BQVCCPGCDUSGOE-UHFFFAOYSA-N 0.000 description 1
150000008300 phosphoramidites Chemical class 0.000 description 1
239000003504 photosensitizing agent Substances 0.000 description 1
230000035790 physiological processes and functions Effects 0.000 description 1
235000002677 phytofluene Nutrition 0.000 description 1
OVSVTCFNLSGAMM-UZFNGAIXSA-N phytofluene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=C\C=C(/C)\C=C\C=C(C)CCC=C(C)CCC=C(C)C OVSVTCFNLSGAMM-UZFNGAIXSA-N 0.000 description 1
ZYSFBWMZMDHGOJ-SGKBLAECSA-N phytofluene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/CCC=C(/C)C=CC=C(/C)CCC=C(C)C)C)C)C)C ZYSFBWMZMDHGOJ-SGKBLAECSA-N 0.000 description 1
239000000049 pigment Substances 0.000 description 1
229920001983 poloxamer Polymers 0.000 description 1
229920000447 polyanionic polymer Polymers 0.000 description 1
125000003367 polycyclic group Chemical group 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
239000011148 porous material Substances 0.000 description 1
230000004481 post-translational protein modification Effects 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
239000000843 powder Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
230000001855 preneoplastic effect Effects 0.000 description 1
238000002953 preparative HPLC Methods 0.000 description 1
210000001236 prokaryotic cell Anatomy 0.000 description 1
230000001915 proofreading effect Effects 0.000 description 1
XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
229940127293 prostanoid Drugs 0.000 description 1
150000003814 prostanoids Chemical class 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
230000012846 protein folding Effects 0.000 description 1
230000004853 protein function Effects 0.000 description 1
230000018883 protein targeting Effects 0.000 description 1
244000000040 protozoan parasite Species 0.000 description 1
238000004445 quantitative analysis Methods 0.000 description 1
150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
238000010791 quenching Methods 0.000 description 1
230000000171 quenching effect Effects 0.000 description 1
239000004172 quinoline yellow Substances 0.000 description 1
150000004053 quinones Chemical class 0.000 description 1
230000006340 racemization Effects 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
208000016691 refractory malignant neoplasm Diseases 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
125000006853 reporter group Chemical group 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
230000027756 respiratory electron transport chain Effects 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
210000001995 reticulocyte Anatomy 0.000 description 1
210000001525 retina Anatomy 0.000 description 1
230000001177 retroviral effect Effects 0.000 description 1
210000003705 ribosome Anatomy 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000013391 scatchard analysis Methods 0.000 description 1
230000002000 scavenging effect Effects 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
238000005204 segregation Methods 0.000 description 1
238000010187 selection method Methods 0.000 description 1
239000006152 selective media Substances 0.000 description 1
238000000926 separation method Methods 0.000 description 1
230000009919 sequestration Effects 0.000 description 1
230000000405 serological effect Effects 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
208000002491 severe combined immunodeficiency Diseases 0.000 description 1
230000011664 signaling Effects 0.000 description 1
QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
229960002930 sirolimus Drugs 0.000 description 1
238000002741 site-directed mutagenesis Methods 0.000 description 1
210000002027 skeletal muscle Anatomy 0.000 description 1
230000000392 somatic effect Effects 0.000 description 1
230000001148 spastic effect Effects 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
230000010473 stable expression Effects 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
230000037351 starvation Effects 0.000 description 1
238000013179 statistical model Methods 0.000 description 1
210000000130 stem cell Anatomy 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
230000004960 subcellular localization Effects 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
UIUJIQZEACWQSV-UHFFFAOYSA-N succinic semialdehyde Chemical compound OC(=O)CCC=O UIUJIQZEACWQSV-UHFFFAOYSA-N 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
238000003419 tautomerization reaction Methods 0.000 description 1
150000003505 terpenes Chemical class 0.000 description 1
108010008054 testis specific phosphoglycerate kinase Proteins 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
231100001274 therapeutic index Toxicity 0.000 description 1
RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
150000003584 thiosemicarbazones Chemical class 0.000 description 1
229960002175 thyroglobulin Drugs 0.000 description 1
108090000721 thyroid hormone receptors Proteins 0.000 description 1
238000012090 tissue culture technique Methods 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
231100000167 toxic agent Toxicity 0.000 description 1
239000003440 toxic substance Substances 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
ZIUDAKDLOLDEGU-UHFFFAOYSA-N trans-Phytofluen Natural products CC(C)=CCCC(C)CCCC(C)CC=CC(C)=CC=CC=C(C)C=CCC(C)CCCC(C)CCC=C(C)C ZIUDAKDLOLDEGU-UHFFFAOYSA-N 0.000 description 1
ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
108091008023 transcriptional regulators Proteins 0.000 description 1
230000002463 transducing effect Effects 0.000 description 1
230000014621 translational initiation Effects 0.000 description 1
238000011269 treatment regimen Methods 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
101150081616 trpB gene Proteins 0.000 description 1
101150111232 trpB-1 gene Proteins 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
108020005087 unfolded proteins Proteins 0.000 description 1
241000701447 unidentified baculovirus Species 0.000 description 1
DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
229940045145 uridine Drugs 0.000 description 1
235000012431 wafers Nutrition 0.000 description 1
QAOHCFGKCWTBGC-QHOAOGIMSA-N wybutosine Chemical compound C1=NC=2C(=O)N3C(CC[C@H](NC(=O)OC)C(=O)OC)=C(C)N=C3N(C)C=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O QAOHCFGKCWTBGC-QHOAOGIMSA-N 0.000 description 1
QAOHCFGKCWTBGC-UHFFFAOYSA-N wybutosine Natural products C1=NC=2C(=O)N3C(CCC(NC(=O)OC)C(=O)OC)=C(C)N=C3N(C)C=2N1C1OC(CO)C(O)C1O QAOHCFGKCWTBGC-UHFFFAOYSA-N 0.000 description 1
150000003735 xanthophylls Chemical class 0.000 description 1
235000008210 xanthophylls Nutrition 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Pharmacology & Pharmacy (AREA)
Biotechnology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Microbiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Engineering & Computer Science (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Enzymes And Modification Thereof (AREA)
Apparatus Associated With Microorganisms And Enzymes (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)

CA002423701A 2000-09-29 2001-09-28 Oxidoreductases Abandoned CA2423701A1 (en)

Applications Claiming Priority (9)

Application Number	Priority Date	Filing Date	Title
US23710100P	2000-09-29	2000-09-29
US60/237,101		2000-09-29
US23848200P	2000-10-06	2000-10-06
US60/238,482		2000-10-06
US24402400P	2000-10-27	2000-10-27
US60/244,024		2000-10-27
US25080500P	2000-12-01	2000-12-01
US60/250,805		2000-12-01
PCT/US2001/030656 WO2002026951A2 (en)	2000-09-29	2001-09-28	Oxidoreductases

Publications (1)

Publication Number	Publication Date
CA2423701A1 true CA2423701A1 (en)	2002-04-04

Family

ID=27499873

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002423701A Abandoned CA2423701A1 (en)	2000-09-29	2001-09-28	Oxidoreductases

Country Status (5)

Country	Link
EP (1)	EP1320585A2 (de)
JP (1)	JP2004524814A (de)
AU (1)	AU2002211324A1 (de)
CA (1)	CA2423701A1 (de)
WO (1)	WO2002026951A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1389238A2 (de) *	2001-04-27	2004-02-18	Bayer HealthCare AG	Regulierung des humanen prostagandin-f synthase 1-ähnlichen proteins
US20060003410A1 (en) *	2004-06-10	2006-01-05	Lee-Ming Chuang	Prostaglandin reductase
EP4166157A4 (de) *	2020-06-16	2024-03-06	Novel Pharma Inc.	Zusammensetzung zur behandlung von glutarazidurie und verabreichungsverfahren dafür

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000000622A2 (en) *	1998-06-30	2000-01-06	Incyte Pharmaceuticals, Inc.	Human oxidoreductase proteins
WO2000020604A2 (en) *	1998-10-06	2000-04-13	Incyte Pharmaceuticals, Inc.	Oxidoreductase molecules
CN1307115A (zh) *	2000-01-28	2001-08-08	上海博道基因技术有限公司	一种新的多肽——人乙醇脱氢酶39和编码这种多肽的多核苷酸

2001
- 2001-09-28 EP EP01979351A patent/EP1320585A2/de not_active Withdrawn
- 2001-09-28 AU AU2002211324A patent/AU2002211324A1/en not_active Abandoned
- 2001-09-28 JP JP2002530715A patent/JP2004524814A/ja active Pending
- 2001-09-28 CA CA002423701A patent/CA2423701A1/en not_active Abandoned
- 2001-09-28 WO PCT/US2001/030656 patent/WO2002026951A2/en not_active Ceased

Also Published As

Publication number	Publication date
AU2002211324A1 (en)	2002-04-08
WO2002026951A3 (en)	2003-03-27
JP2004524814A (ja)	2004-08-19
EP1320585A2 (de)	2003-06-25
WO2002026951A2 (en)	2002-04-04

Legal Events

Date	Code	Title	Description
2005-06-29	FZDE	Dead

Publication	Publication Date	Title
CA2408315A1 (en)	2001-11-29	Aminoacyl trna synthetases
CA2380317A1 (en)	2001-02-01	Human synthetases
US20040253588A1 (en)	2004-12-16	Drug metabolizing enzymes
WO2001051638A2 (en)	2001-07-19	Drug metabolizing enzymes
WO2003004608A2 (en)	2003-01-16	Drug metabolizing enzymes
CA2394160A1 (en)	2001-06-21	Human oxidoreductase proteins
EP1254236A2 (de)	2002-11-06	Arzneimittelmetabolisierende enzyme
WO2001079468A2 (en)	2001-10-25	Drug metabolizing enzymes
CA2423701A1 (en)	2002-04-04	Oxidoreductases
CA2417769A1 (en)	2002-02-14	Drug metabolizing enzymes
EP1360304A2 (de)	2003-11-12	Enzyme
CA2413810A1 (en)	2002-01-17	Aminoacyl trna synthetases
WO2000071679A2 (en)	2000-11-30	Human oxidoreductase proteins
US20040054157A1 (en)	2004-03-18	Oxidoreductases
CA2431139A1 (en)	2002-06-27	Oxidoreductases
US20030124106A1 (en)	2003-07-03	Human oxidoreductase proteins
EP1259618A2 (de)	2002-11-27	Menschliche enzymmoleküle
CA2443244A1 (en)	2002-10-24	Enzymes
CA2414010A1 (en)	2001-12-27	Secreted redox proteins
US20040086887A1 (en)	2004-05-06	Drug metabolizing enzymes
US20040053252A1 (en)	2004-03-18	Secreted redox proteins
WO2002090521A2 (en)	2002-11-14	Drug metabolizing enzymes
EP1395656A2 (de)	2004-03-10	Humane arzneimittelmetabolisierende enzyme
WO2002040658A2 (en)	2002-05-23	Isomerases